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RESUME 
D'une part, le dicer, l'endoribonucléase RNase III responsable de la maturation des 
microARN, aurait été réduit chez les adipocytes au cours du vieillissement. Avec l'utilisation 
de souris dicerlox / lox / adiponectine-CreERT2 inductibles par le tamoxifène, nous avons 
constaté que le déficit en adipocytes favorisait l'apparition de certaines complications liées à 
l'âge, telles que la réduction de la taille des adipocytes et le dysfonctionnement du 
métabolisme. L'abrogation des marqueurs adipocytaires blancs, tels que Pparγ, Glut4 ou Hsl, 
indique que le dicer est indispensable au maintien de l'identité des adipocytes blancs. De 
plus, les résultats montrant une accumulation de lipides et une fibrose hépatique chez des 
souris traitées par le damerlox / lox / adiponectine-CreERT2 + traitées au tamoxifène ont 
indiqué que la carence en adicocyte pourrait contribuer au vieillissement du foie. 
Mécaniquement, la fonction mitochondriale semblait être régulée à la hausse en 
raison d'une déficience en dicer adipocytaire, indiquée par une augmentation des taux de 
protéines des composants d'OXPHOS et de PGC1α. En ligne, les répresseurs des 
mitochondries FOXO1 et FOXO3 ont été phosphorylés et inactivés, dont les cibles 
antioxydantes en aval, la Catalase et le Sod, ont également diminué. En outre, P16, un 
marqueur de la sénescence, a montré une tendance à augmenter en raison de la carence en 
dicer. Comme le surplus de ROS mitochondrial peut entraîner des dommages à l'ADN et la 
sénescence, nous avons assuré que la déficience en dicer adipocytaire pourrait induire une 
combinaison d'activation mitochondriale et une réduction de la réduction de la 
détoxification possiblement induite par l'inactivation de FOXO1 et FOXO3a. Enfin, le résultat 
selon lequel la restriction en éléments nutritifs a régulé positivement le taux de dicer dans 
les adipocytes a également confirmé qu'il existe une voie de vieillissement conservée dans 
les adipocytes impliquant le dicer. 
Par ailleurs, grâce à la sélection de microréseaux et à la validation RT-qPCR, nous 
avons rapporté que le vieillissement augmentait le mir-1949 dans les adipocytes chez les 
souris de type sauvage et favorisait probablement sa sécrétion à partir du tissu adipeux 
perigonadal in vitro. De manière correspondante, des résultats in vitro ont également 
suggéré que la sénescence augmentait la production de mir-1949 et la sécrétion 
d'adipocytes. Sur le plan fonctionnel, la régulation positive du mir-1949 dans les adipocytes 
 
 
3T3-F442A régulait négativement le niveau du complexe mitochondrial II et la capacité de 
consommation d'oxygène, associées à l'accumulation de lipides. Fait intéressant, la 
régulation à la hausse soutenue du mir-1949 au cours de l'adipogenèse des préadipocytes 
3T3-F442A avait tendance à augmenter les marqueurs adipocytaires blancs, tels que la 
leptine, Glut4 ou Hsl (N = 2). Enfin, combiné aux résultats indiquant que le jeûne de 24 
heures a significativement augmenté le mir-1949 dans les tissus adipeux péri-radicaux et que 
la régulation positive du mir-1949 tendait à augmenter l'accumulation de lipides dans les 
adipocytes séniles 3T3-F442A (N = 1) augmente l'expression de mir-1949 dans les adipocytes, 
ce qui pourrait tenter de sauver des dysfonctionnements liés à l'âge dans les adipocytes, tels 
qu'une altération du stockage des lipides. Néanmoins, les actions précises de mir-1949 
doivent être validées in vivo par injection de mimétique d'AAV-aP2-mir-1949 chez des souris 
âgées. 
Parallèlement à mon projet de thèse, nous avons dû moduler les expressions 
géniques dans des adipocytes différenciés à partir de lignées cellulaires immortalisées avec 
des techniques de routine telles que les transfections d'ARNsi. Nous avons donc cherché à 
développer une technique permettant de conserver des adipocytes isolés pour des 
expériences. À l'aide d'inserts de culture cellulaire, nous avons réussi à séquencer des 
adipocytes matures flottants et à les exposer à l'air. En outre, en réduisant la tension de 
surface avec la supplémentation en co-solvants, le taux de survie des cellules adipeuses en 
culture a apparemment augmenté. Ensuite, les résultats de la qPCR ont démontré que les 
taux d'ARNm des marqueurs des adipocytes augmentaient après presque une semaine de 
culture, ce qui correspondait à la taille accrue des cellules. En outre, les adipocytes cultivés 
dans notre système de culture se sont avérés fonctionnels, pouvant répondre 
respectivement à la stimulation catécholamine / insuline pour la lipolyse et le transport du 
glucose. Par conséquent, la nouvelle façon dont nous avons invité est capable de rester des 
adipocytes matures pour une étude in vitro sans perdre ses caractéristiques de morphologie 
et de fonction. 
Ensemble, ces deux aspects de ma thèse nous amèneraient à mieux comprendre le 
domaine des adipocytes et du vieillissement. 
Mots-clés: Vieillissement, adipocytes, dicer, mir-1949 
 
 
ABSTRACT 
On the one part, dicer, the RNase III endoribonuclease responsible for microRNAs 
maturation, has been reported to be decreased in adipocytes during ageing. With the use of 
tamoxifen inducible dicerlox/lox/ adiponectin-CreERT2 mice, we found that adipocyte dicer 
deficiency promoted the onset of some of the age-related complications, such as reduced 
adipocyte sizes and dysfunctions in systemic metabolism. The abrogation of white adipocyte 
markers such as Pparγ, Glut4 or Hsl, indicated that dicer is indispensible for the 
maintainance of white adipocyte identity. In addition, the results that there were lipid 
accumulation and fibrosis in liver in tamoxifen treated dicerlox/lox/ adiponectin-CreERT2+ mice, 
indicated that adipocyte dicer deficiency might contribute to liver aging.  
Mechanistically, mitochondrial function seemed to be upregulated due to adipocyte 
dicer deficiency, indicated by increased protein levels of OXPHOS components and PGC1α. In 
line, mitochondria repressors FOXO1 and FOXO3 were phosphorylated and inactivated, 
whose downstream antioxidant targets Catalase and Sod were also decreased. Moreover, 
P16, a marker of senescence, exhibited a trend to be increased due to adipocyte dicer 
deficiency. Since mitochondrial ROS surplus can lead to DNA damage and senescence, we 
assured that adipocyte dicer deficiency might induce a combination of mitochondrial 
activation and reduction in detoxification reduction possibly mediated by the inactivation of 
FOXO1 and FOXO3a. Finally, the result that nutrient restriction positively regulated dicer 
level in adipocytes further supported that there is a conserved aging pathway in adipocytes 
involving dicer. 
On the other part, through microarray screen and RT-qPCR validation, we reported 
that aging increased mir-1949 in adipocytes in wild type mice and possibly promoted its 
secretion from perigonadal adipose tissue in vitro. Correspondingly, in vitro results also 
suggested that senescence increased mir-1949 production and secretion from adipocytes. 
Functionally, upregulation of mir-1949 in 3T3-F442A adipocytes negatively regulated 
mitochondrial complex II protein level and oxygen consumption capability, associated with 
lipid accumulation. Interestingly, sustained upregulation of mir-1949 during adipogenesis of 
3T3-F442A preadipocytes, tended to increase white adipocyte markers, such as Leptin, Glut4 
or Hsl (N=2). Finally, combined with the results that 24h fasting significantly increased mir-
 
 
1949 in perigonadal adipose tissue as well as that upregulation of mir-1949 exhibited a trend 
to increase lipid accumulation in senescent 3T3-F442A adipocytes (N=1), we assured that 
aging increases mir-1949 expression in adipocytes which might try to rescue age-related 
dysfunctions in adipocytes, such as impaired lipid storage. Nevertheless, the precise actions 
of mir-1949 need to be validated in vivo by injection of AAV-aP2-mir-1949 mimic into aged 
mice. 
In parallel of my PhD project, we faced the matter of modulating gene expressions in 
differentiated adipocytes from immortalized cell lines with routine techniques like siRNA 
transfection. Therefore, we aimed to develop a technique enabling us to conserve isolated 
adipocytes for experiments. With the help of cell culture inserts, we managed to sequence 
buoyant mature adipocytes from floating and exposing into air. Moreover, by reducing 
surface tension with supplementation of co-solvents, the survival rate of cultured fat cells 
was apparently increased. Then, RT-qPCR results demonstrated that mRNAs levels of 
adipocytes markers increased after nearly one week of culture, in consistent with the 
increased cell sizes. Besides, cultured adipocytes in our culture system were proved to be 
functional, being able to response to catecholamine/ insulin stimulation for lipolysis and 
glucose transport, respectively. Therefore, the new way that we invited is capable of 
remaining mature adipocytes for in vitro study without losing its characteristics of 
morphology and function. 
Taken together, these two aspects of my PhD would lead us to understand more in 
the field of adipocytes and aging. 
 
Key words: Aging, adipocytes, dicer, mir-1949  
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Introduction 
PART I: White adipose tissue and aging 
1. The adipose tissue 
The adipose tissue is a master regulator of energy balance and nutritional 
homeostasis. Viewed as an inert energy storage site and a form of connective tissue not long 
time ago, surging evidence now have revealed that adipose tissue is a remarkably complex 
organ with important endocrinal functions which enable its crosstalk with diverse organs. 
Moreover, with the very recent discovery of brown and beige adipocytes, interests have 
been fueled in the study of adipose biology (Figure 1). 
 
 
Figure 1: Growing interests in adipose biology over the last century.  
 
Adopted from
2
. 
 
Adipose tissue is a dynamic organ which can range from 4% to over 40% of total body 
composition in adult humans and is dispersed throughout human body. Founctionally, 
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adipose tissue could be categorized into white adipose tissue (WAT) and brown adipose 
tissue (BAT). BAT generates heat during cold exposure by adaptive thermogenesis to 
maintain normal body temperature and is more abundant in neonates and young children, 
and gradually declined in human adults3. Here in our topic, we are going to focus mainly on 
WAT. 
Geographically, WAT is categorized into subcutaneous and visceral adipose tissue 
(sWAT and vWAT, respectively) (Figure 2a). Surprisingly, a pioneering clinical study in the 
1950s firstly reported that location of fat depots has a great influence on the likelihood of an 
individual to develop many of the complications of obesity4 (Figure 2b).  The data indicate 
that there is heterogeneity between sWAT and vWAT. 
 
 
Figure 2: Adipose tissue distribution associates with the incidence of diabetes development.  
(a) Distributions of WAT in human. (b) Incidence of development of diabetes associated with the fat 
distributions. Modified from
5
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1.1. Subcutaneous adipose tissue (sWAT) 
In human, sWAT forms just below the dermis, and includes periscapular and inguinal 
depots. Increased amounts of subcutaneous fat, especially in the gluteofemoral regions, are 
associated with improved insulin sensitivity and a lower risk of developing metabolic 
12 
 
syndromes6. In mice, transplantation of subucutaneous fat into the cavity of visceral fat 
significantly decreases body weight and total fat mass as well as improves systemic glucose 
tolerance, whereas transplantation of vWAT into the depot of sWAT has little effects7. 
The metabolic benefits of sWAT might be associated with its unique property: sWAT 
is capable of ‘browning’ in responsive to cold exposure, β-agonists or other hormone-like 
stimuli8, which includes the induction of uncoupling protein 1 (UCP1)  expression, a gene 
giving rise to uncoupled respiration and heat production. The UCP positive cells would 
emerge in white fat depots under certain stimuli and are termed beige or brite cells. 
Adipocyte-specific mutant of PR domain containing 16 (PRDM16) markedly inhibites beige 
adipocyte function in sWAT following cold exposure or β3-agonist treatment, acquiring 
numerous properties of vWAT including decreased thermogenic and increased inflammatory 
gene expression as well as macrophage infiltration. Moreover, transplantation of the sWAT 
derived from PRDM16 mutants into obese mice shows a loss of metabolic benefit9. 
Recently, it has been reported that inhibitors of the Janus kinase/ signal transducers 
and activators of transcription 1/3 (JAK/ STAT1/3) signaling, like tofacitinib and R406 are 
strongly inducers of UCP1 exressionin sWAT but not in vWAT10, indicating that inhibitions of 
JAK/ STAT1/3 signaling might mediate the browning process in sWAT, whereas it is not 
employed in the futile energy cycle in vWAT. 
 
1.2. Visveral adipose tissue (vWAT) 
In human, there are 6 visceral fat depots: perirenal, gonadal, epicardial, 
retroperitoneal, omental and mesenteric depots. In contrast to sWAT, it is revealed that the 
size of abdominal adipocyte is a significant risk predictor for the development of type 2 
diabetes, as revealed by a follow-up study of around 245 women from 1974 to 200111. 
Several plausible mechanisms may be associated with the properties of vWAT. 
Firstly, Aliki Kosteli et al, demonstrat that vWAT has a higher rate of basal lipolysis 
and therefore releases more free fatty acids (FFAs) compared to sWAT12. Since vWAT is 
anatomically drained by the portal vein, the increased levels of portal FFAs might induce 
metabolic complications in liver, such as hepatic steatosis or hepatic insulin resistance in 
13 
 
obesity13. What’s more, FFAs are also strong inducers of adipose tissue’s recruitment of 
macrophages, whose chronic accumulation would lead to elevated local inflammatory 
state12, which is negatively associated with insulin resistance. In addition, with the use of 
whole-body fluorodeoxyglucose positron emission tomography (FDG-PET) scans, it is found 
that vWAT has higher rates of glucose uptake compared to sWAT in both lean and obese 
humans. The isolated stromal vascular fractions (SVFs) from vWAT exhibites significant 
increase in both basal and cytokine stimulated glucose consumptions associated with a 
higher expression of hexokinase (HK) compared to that from sWAT14. These results indicate 
that vWAT has higher metabolic rates in comparision to sWAT. 
Interestingly, although to a lesser extent, visceral fat is capable of responding to 
chronic β3-adrenergic receptor stimulation demonstrated by the appearance of lipid droplet 
mutilocularity and robust mitochondrial biogenesis, which might be explained by a 
prominent increase in futile creatine cycling in visceral fat under stimulation15. However, the 
physiological role of futile cycling of vWAT remains to be investigated. 
Secondly, vWAT is also an endocrine organ that actively secretes lots of cytokines and 
bioactive mediators, which influence systemic inflammation, lipid metabolism and insulin 
sensitivity16. For example, B cells isolated from vWAT expressed higher levels of 
inflammatory immune activation markers and significantly higher nuclear factor-κB (NF-κB) 
activation and phospho-STAT317. Expression of proinflammatory adipokines in vWAT could 
be elevated by obesity, which might contribute to their circulating elevation during obesity18. 
2. White Adipocytes 
Adipose tissue is composed of mature adipocytes and various other cell types in 
stromal vascular factions (SVFs) that include leukocytes (e.g., macrophages and lymphocytes) 
and adipose tissue stromal cells (ATSCs) that include preadipocytes and fibroblasts. 
Adipocytes contribute mainly to metabolism and functions of adipose tissue19. 
2.1. Architecture 
White adipocytes contain a single large lipid droplet (LD) occupying approximately 90% 
of the cytoplasm, with the nucleus being squeezed to the cell periphery and the cytoplasm 
14 
 
forming a very thin rim. Mitochondria are scarce and internal cristae are poorly developed 
(Figure 3). Due to these characteristics, these cells are also termed unilocular adipocytes. 
 
Figure 3: Representation and transmission electron microscopy of the morphology of white adipocytes.  
Abbreviations: L, lipid; M, mitochondria; N, nucleus. Modified from
20
. 
 
At the tissue level, spherical adipocytes are typically arranged in an imperfect 
hexagonal packing architecture resembling honeycomb, with smaller preadipocytes and 
interweaving capillaries and nerves filling the interstitial space21,22.  Adipocytes themselves 
are interconnected via gap junctions and thereby share cytoplasm and respond in concert to 
electrical stimuli23. Additionally, adipocytes are intensively interacted with the extracellular 
matrix (ECM), which provides both the flexibility needed for cell migration and hypertrophy 
and the stability needed for the structural and functional integrity of the tissue as a whole 
(Figure 4). For example, adipocytes are interacted with an isotropic network of collagen and 
elastic fibers, extracellular fibronectin and laminin24, via attachment points for integrins 
anchored in the adipocyte membrane25. 
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Figure 4: Extracellular support of adipocytes in vivo.  
Structural support is provided by type I (100 nm to 100 µm diameter) and type VI (50 nm diameter) collagen 
networks. The LD is caged in vimentin (10 nm, brown filament). The nucleus (blue) moves to the cell periphery 
and is deformed by the LD. Modified from
26
. 
 
 
The rounded LDs are surrounded by a single lipid layer (of endoplasmic reticulum 
membrane origin), which is in turn ensheathed by endoplasmic reticulum (ER). LDs are very 
ofter surrounded by one or more proteins of the PAT (perilipin, adipose differentiation-
related protein (ADRP), and TIP47 (tail interacting protein of 47 kDa family)27. The LDs of 
adipocytes are encased in a coating of perilipins, which have an important role in regulating 
triglyceride hydrolysis (breakdown of triglyceride into glycerol and free fatty acids), with 
perilipin A being the most abundant isoform in adipocytes. Perilipin null adipocytes exhibites 
elevated basal lipolysis but attenuated sitmulated lipolytic activity, indicating that perilipin is 
required for maximal lipolytic activity28. 
 
2.2. Homeostasis of lipid droplets in adipocytes 
Adipocytes are central in the regulation of triglyceride (TG) and FFAs homeostasis 
during energy expenditure and deprivation. The storage and removal of TG in adipocytes is 
essential to determine the sizes of adipocytes. In vivo, the sizes of adipocytes vary greatly 
according to the depots and the nutritional states (Table 1). The sizes of adipocytes correlate 
with the functions of adipocytes. It has been demonstrated that small white adipocytes have 
lower expression of enzymes involved in fatty acids use (β-oxidation) including acyl-CoA 
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dehydrogenase and carnitine palmitoyl transferase 2 (CPT2), as well as in fatty acid synthesis 
(FAS) compared to large white adipocytes, coinciding with that fact that small adipocytes 
have low storage of TG29. 
 
Table 1: The average sizes of adipocytesin developing and adult human 
a
25-30 weeks gestation,
b
1-3 months postpartum. Adopted from
30
. 
 
 
Several major functions of adipocytes determine the size of LDs in adipocytes: fatty 
acid uptake, de novo lipogenesis (DNL), lipolysis and possible burning of fat by beiging, which 
we will discuss in details in the following parts. 
 
2.2.1. Synthesis  of lipid droplets (LDs) 
 Fatty acid uptake 
Most of the lipids stored in adipocytes are transferred directly from diets. Several 
proteins are involved in fatty acid uptake in adipocytes: caveolin-1, fatty acid translocase 
(FAT/CD36), the 43-kDa plasma membrane fatty acid binding protein (FABPpm), and fatty 
acid transport protein (FATP), adipose acyl CoA synthetase (ACSL). 
Caveolin-1 
Caveolae are a subset of so-called membrane lipid raft domains that are often 
experimentally defined by their resistance to solubilization by nonionic detergents. 
The surface of adipocytes is abundantly covered by caveolae (nearly 30%)31. Caveolin-1 is the 
primary protein driving the formation of caveolae in adipocytes32. Caveolin-1 is speculated to 
bind the fatty acids accumulated with the caveolar membrane, leading to membrane 
asymmetry and budding of caveolae from plasma membrane to form vesicles. These fatty 
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acid loaded caveolae vesicles could deliver fatty acids to subcellular compartments for 
further metabolism (Figure 5)33. 
FABPpm 
Expression of FABPpm in 3T3-L1 preadipocytes that normally do not express FABPpm 
induces a significant increase in fatty acid uptake. Anti-FABPpm antibodies selectively inhibit 
uptake of oleate in 3T3-L1 adipocyte monolayer without affecting 2-deoxyglucose or 
octanoate (medium-chain fatty acid) uptake34. Currently, the mechanism by which FABPpm 
used in LCFA uptake is unknown. 
CD36 
CD36 is an 88-kDa single chain membrane glycoprotein expressed in many tissues 
and cell types, including adipocytes, heart, skeletal muscle and macrophages. C/EBPα and 
C/EBPβ would increase CD36 expression in different types of cells, with C/EBPα exhibits a 
significantly higher potency than C/EBPβ. A C/EBP responsive element is identified in the 
CD36 promoter35. It has been speculated that CD36 may bind and internalize long chain fatty 
acid (LCFA) by endocytosis or may bind LCFA and work in concert with FABP to provide a 
high concentration gradient of LCFA across the plasma membrane facilitating its uptake by 
other fatty acid transporters (Figure 5)33. 
FATP1 and ACSL 
FATP1 and ACSL are two different classes of membrane bound enzymes catalyzing 
the ATP-dependent esterification of long-chain and very long-chain fatty acids into acyl-CoA 
derivatives36,37. FATP1 and ACSL1 are enriched in adipose tissue. 
FATP1 is induced during the differentiation of 3T3-L1 adipocytes, and increased LCFA 
uptake. Insulin could trigger FATP1 translocation from a perinuclear compartment to the 
plasma membrane, indicating that FATP1 is facilitated by insulin38. Since it is reported that 
the conversion of incoming LCFA to TG occurs on/or around the plasma membrane in rat 
adipocytes39, FATP1 might facilitate LCFA uptake by tightly coupling it to metabolism: by 
converting it into acyl-CoAs which is preferentially shunted into TG synthesis (Figure 5)33. 
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ACSL1 is found to be involved in the reacylation of LCFA released from the LD during 
basal and hormone-stimulated lipolysis. Acylation of LCFA leads to reincorporation into the 
TG thereby preventing its cellular efflux40. 
 
 
Figure 5: Schematic representation of FFA uptake mediated by CD36 in caveolin-1-FABP rich microdomain.  
Adopted from
33
. 
 
 De novo lipogenesis (DNL) 
On the other hand, adipocytes are capable of synthesizing new lipids from 
carbohydrates through DNL. The two major enzymes of DNL, fatty acid synthase (FAS) and 
acetyl CoA carboxylase (ACC), which are under the control of carbohydrate-response-
element-binding protein (ChREBP) or sterol-response-element-binding protein 1c (SREBP1c), 
are abundantly expressed in fat cells41. Surprisingly, DNL contributes only a few percent of 
fatty acids to the TG that accumulates in the lipid droplets of adipocytes42. In addition, it was 
found that in vitro 3T3-L1 adipocytes preferentially use glycolysis to depose glucose into 
lactate even with the abundant oxygen availability, while only a small fraction of carbon 
from glucose would be converted into TG43. However, DNL contributes to a number of 
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adipose-derived putative bioactive lipids, such as palmitoleate44, the novel fatty acid esters 
of hydroxy-fatty acids45 and PPARγ ligand alkyl ether-lipid46. In addition, studies have shown 
that up-regulation of DNL in adipose tissue mediated the improved insulin sensitivity and 
glycemic control of GLUT4 overexpression in adipocytes, whereas loss of ChREBP has the 
opposite effects41,47. Besides, FAS was dramatically upregualted in WAT by caloric restriction 
(CR) process which is associated with increased insulin sensitivity and longevity, indicating 
that DNL might be important metabolic adaptations of caloric restriction benefits48. 
Conversely, impairment of DNL, which is under rictor/mTORC2 signaling in adipose tissue, 
was found to be necessary for the loss of insulin sensitivity induced by high fat diet in wild 
type mice49. 
Glucose transport: 
Insulin signaling plays an important role in lipid storage and the process of 
adipogenesis for adipocytes (Figure 6). The phosphatidylinositol-3-OH kinase (PI(3)K)-
dependent signaling is initiated by binding of insulin onto its tyrosine kinase receptor on the 
cell surface, leading to the recruitment and tyrosine phosphorylation of the insulin receptor 
substrate (IRS). The phosphorylated IRS then serves as docking sites for the SH2 domain of 
the p85 regulatory subunit of class I PI3K, resulting the activation of PI3K, which promotes 
the synthesis of phosphatidylinositol-3,4,5-trisphosphate PtdIns(3,4,5) P3  from PtdIns (4,5) 
P2 at the plasma membrane. PtdIns(3,4,5) P3  then serves as a docking site for several PH 
domain-containing Ser/Thr kinases that are implicated in glucose uptake, such as 
phosphoinositide-dependent kinase 1 (PDK 1) and AKT (also known as PKB) 50. AKT was then 
activated by PDK1 (phosphoinositide-dependent kinase 1) and mTORC2 through dual Ser/Thr 
phosphorylation. Downstream, AKT kinase affects the exocytic arm of the GLUT4 (glucose 
transporter 4) trafficking itinerary, probably by regulating the translocation, targeting and 
fusion of GLUT4-containing vesicles51. 
On the other hand, insulin could also initiate a PI3K-independent signaling by 
recruiting the adaptor protein APS, which has high affinity to the activated insulin receptor52. 
Following insulin stimulation, APS  recruits a complex that comprises the proto-oncogene c-
CBL and c-CBL-associated protein (CAP), triggering tyrosine phosphorylation of CBL by insulin 
receptor53. Upon phosphorylation, CBL is then translocated to lipid rafts, recruiting the CrkII-
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C3G complex to lipid rafts, where C3G specifically activates the small GTP-binding protein 
TC10, which interacts with effector proteins that regulate GLUT4 vesicle exocytosis54. 
Adipocyte GLUT4 ablation resulted in systemic insulin resistance in liver and muscle55, 
indicating that GLUT4 mediated glucose transport in adipocytes is indispensable for whole 
body glucose homeostasis. 
 
 
Figure 6: Insulin signaling regulates GLUT4 exocytosis by engaging the trafficking machinery.  
Modified from
56
. 
 
 
2.2.2. Hydrolysis of lipid droplets 
Lipolysis represents the process for FFAs to be liberated from TG in LDs. Total lipolysis 
is the sum of basal lipolysis and stimulated lipolysis. Basal lipolysis is the relase of FFAs from 
adipocytes occurring in the absence of negative energy balance, which correlates positively 
with adipocyte size and is increased by obesity57. Stimulated lipolysis refers to the 
hormonally regulated release of FFAs in response to nutritional demands. The lipolysis of TG 
in adipocytes is under tight control of various pathways in vivo (Figure 7). 
Typically, the main regulating signaling pathway of stimulated lipolysis in adipocytes 
is β-adrenergic signaling. At least three major enzymes are responsible for the lipolytic 
process. The primary cleavage of TG to diacylglycerols is performed by the adipose tissue 
lipase (ATGL), which is predominantly expressed in adipose tissue. In ATGL-/-mice, absence of 
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ATGL induced severe lipid accumulation in adipose tissues and heart, with dramatic 
inhibition of basal and isoproterenol stimulated lipolysis as well as premature death. On the 
contrary, the inability of fat catabolism due to ATGL deficiency led to increased glucose use, 
indicating that ATGL is rate limiting in the catabolism of cellular fat58. Administration of 
Atglistain, a small molecule inhibitor of ATGL effectively improves high fat diet-induced 
obesity associated insulin resistance and liver steatosis in mice. Moreover, the drug 
predominantly targeted adipose tissue and the liver, and therefore did not induce cardiac 
lipid accumulation or cardiomyopathy even after long-term treatment59. ATGL is highly 
regulated at both the transcriptional and post-transcriptional levels, including multiple 
phosphorylation events and translocation to the surface of LDs. It could be activated by its 
coactivator comparative gene identification-58 (CGI-58), which is normally bound in an 
inactive state by the LD protein perilipin 1 (PLIN1). And upon activation of β-adrenergic 
signaling, PKA induced phosphorylation of PLIN1 leading to the release of CGI-58, allowing its 
binding and activation of ATGL60. 
Subsequently, hormone-sensitive lipase (HSL) is dispensable for lipolysis. HSL is the 
major diglyceride lipase in adipocytes, with monoglyceride lipase (MGL) completes the 
process by generating glycerol and FFAs. Together, these three enzymes account for over 90% 
of the lipolytic activity in the adipocytes61. 
Physiologically, insulin is the major suppressor of lipolysis, which functions through 
several different ways to block lipolysis: 1) It activates phosphodiesterase 3b (PDE3b) in a 
AKT dependent manner, which antagonize the intracellular levels of cAMP and thereby 
blocking protein kinase A (PKA) activation62. 2) Recently, a non-canonical pathway has been 
proposed in which insulin blocks activation of PKA selectively on PLIN1 through a PI3K-
mediated, AKT-independent pathway63. 3) Insulin could also repress lipolysis by 
transcriptionally silencing lipase genes via repressions of transcription factors forkhead box 
protein O1 (FOXO1) and interferon regulatory factor 4 (IRF4)64 (Figure 7). 
The size of fat cells per se also have an impact on both the spontaneous and 
hormone-stimulated rates of lipolysis, with big adipocytes exhibited higher rates of basal and 
hormone-stimulated hydrolysis, probably owing to the fact that hypertrophic adipocytes are 
enriched in the expressions of ATGL, HSL and PLIN1. However, the receptor sensitivities for 
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hormones like insulin, natriuretic peptides, dobutamine, terbutaline and clonidine, are 
comparable between small and large fat cells65. 
 
 
Figure 7: Tight control of lipolysis process by IIS, β-adrenergic signaling and NP receptor A signaling pathways.  
Adopted from
62
. 
 
2.2.3. Lipid driplets “burning” 
Over the last three decades, it has been realized that mature adipocytes displayed 
high plasticity, especially those in the subcutaneous depots. In response to some external 
stimuli, including chronic cold exposure, exercise, long-term treatment with PPARγ agonists 
or β3-adrenergic receptor agonists, cancer cachexia, and tissue injury, a group of beige (also 
called brite) adipocytes are induced within WAT which are characterized by possessions of 
abundant cristae-dense mitochondria that express UCP1 and mutilocular LDs66. Fatty acids 
are rapidly consumed and deprived by mitochondria β-oxidationa and UCP-mediated heat 
production in beige adipocytes, resulting in a smaller appearance of beige adipocytes 
compared to normal white adipocytes67. It also has been demonstrated that beige-like 
adipocytes also exist in human adults68. 
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Although some of beige adipocytes might directly come from adipogenesis of 
distinctive populations of progenitors within WAT69,70, it has been reported that stimulation 
of β3-adrenergic receptor (Adrb3) in mature adipocytes could directly lead the 
transformation into mitochondrial abundant beige adipocytes via activation of PRDM71. 
Conversely, after withdrawal of external stimuli such as cold acclimation or β3- 
adrenergic agonists, the produced beige adipocytes then possibly transform into normal 
white adipocytes, by upregulation of mitophagy (mitochondrial clearance via autophagy) 
activated by which is initiated by the activation of MiT/TFF (microphthalmia/ transcription 
factor E) transcription factor-mediated lysosome biogenesis67. 
 
2.3. Endocrinal functions 
Adipocytes have been well acknowledged as a bona fide endocrine cell type that 
regulates systemic metabolic homeostasis in accordance to nutrient flux by equally matching 
the metabolic demands of positive or negative energy balance, via secreting a variety of 
bioactive peptides, known as adipokines (Figure 8). Secretion of adipokines, including leptin, 
adiponectin, bone morphogenetic protein (BMP)-4, dipeptidyl peptidase 4 (DPP-4), etc, is 
altered by adipose dysfunction and may contribute to obesity-associated diseases. Therefore, 
adipokines are promising candidates for pharmacological treatment and as diagnostic tools. 
Leptin 
Leptin was discovered more than 20 years ago72. Circulating levels of leptin are 
proportional to fat mass, and leptin receptors are abundantly expressed in various tissues, 
including on the adipocyte. Leptin negatively regulate adiposity. Indirectly, leptin negatively 
regulate satiety via inhibiting the orexigenic pathway comprising neuropeptide-Y (NPY) and 
agouti-related protein (AGRP)-containing neurons, while upreguation of anorexigenic 
pathway consisting of proopiomelanocortin (POMC) and cocaine- and amphetamine-
regulated transcript (CART)-containing neurons in hypothalamus73. Moreover, leptin would 
drive adiposity depletion by stimulation of lipolysis through activating sympathetic neurons 
innervating adipocytes in WAT in vivo74. Also, in vitro, leptin was reported to decrease 
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lipogenesis, increase TG hydrolysis and oxidation of fatty acids in isolated rat white 
adipocytes75. 
Adiponectin 
Adiponectin was firstly reported in 199576, which is almost exclusively synthesized by 
adipocytes. Adiponectin concentrations inversely correlate with fat mass and are down-
regulated in obesity and type 2 diabetes77.Overexpression of adiponectin in 3T3-L1 cells 
enhanced adipogenesis and lipid storage78. Also, adiponectin has been shown to increase 
insulin sensitivity and maintains healthy adipose tissue expansion while rescuing ectopic lipid 
accumulation in mice79. 
The beneficial effects of adiponectin on insulin sensitivity seem to be mediated in 
part by its ability to activate AMP-activated protein kinase (AMPK) in skeletal muscle and 
liver80.For example, adiponectin decreases hepatic lipogenesis and increases β-oxidation 
through activation of AMPK, a cellular energy sensor, inhibits lipogenesis by phosphorylating 
the rate-limiting enzyme of DNL, acetyl CoA carboxylase-1 (ACC-1). This decreases in ACC-1 
activity which leads to decrease in malonyl CoA production, thereby relieves inhibition of 
carnitine palmitoul transferase-1 (CPT-1) activity and enhances fatty acid transport into the 
mitochondria to undergo β-oxidation. 
Adiponectin is also associated with cardio-protection. Administration of adenovirus-
mediated adiponectin reduces atheroscleric lesion size in apolipoprotein E knockout mice, 
accompanied by reduction in the expression of inflammatory cytokines81. Moreover, 
adiponectin is also reported to promote angiogenesis and inhibits endothelial apopotosis82. 
Fatty acid binding protein 4 (FABP4/ aP2) 
aP2 was elevated in circulation in obese humans and mice83. Furthermore, aP2 was 
demonstrated to be an adipokine released from adipocytes under obesogenic conditions, 
such as hypoxia, to augment insulin secretion from pancreatic β-cells in vivo, while insulin 
could in turn inhibit aP2 secretion84. 
DPP-4 
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Dipeptidyl peptidase 4 (DPP4) is a 110 kDa glycoprotein, which is ubiquitously 
expressed on different cell types as well as in circulation. By proteomic profiling of the 
adipocyte secretome, soluble DPP4 is identified as a novel adipokine, for which mature 
adipocytes constitute are a major source85. DPP-4 may not only reflect, but also contribute 
to adipose tissue dysfunction. Compared with healthy lean individuals, patients with obesity 
and insulin resistance have higher DPP-4 expression in vWAT, which may contribute to the 
higher circulating DPP-4 levels86. In obesity, hypoxia-mediated upregulation of DPP-4 
shedding from adipocytes by metalloprotease-9 might contribute to induced DPP-4 activity87. 
Also, in mice, production of DPP-4 in adipocytes is shown to be negatively regulated by high 
glucose concentration under physiological conditions, such an effect is abolished in mouse 
models of diabetes88. 
Under physiological conditions, DPP-4 rapidly degrades the incretin hormones 
including glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 
(GLP-1)89, which have been shown to enhance glucose-dependent insulin secretion and 
inhibit glucagon secretion, which together may reduce hepatic gluconeogesis90. Moreover, 
under physiologic concentrations, DPP-4 directly induced insulin resistance in adipocytes and 
skeletal muscle85 
Nicotinamide phosphoribosyltransferase (NAMPT) 
Very recently, NAMPT, a key NAD+ biosynthetic enzyme, which has two different 
forms, intra- and extracellular (iNAMPT and eNAMPT) in mammals, was found predisposed 
to secretion from adipocytes via deacetylation by the mammalian NAD+-dependent 
deacetylase SIRT1. Adipose tissue-specific NAMPT knockout and knockin mice show 
reciprocal changes in circulating eNAMPT, affecting the hypothalamic NAD+ production, SIRT 
activity and neural activation accordingly91. The story provides an elegant example in which 
adipocyte-derived molecules could be transferred and exert their function in other organs. 
BMP-4 
BMP-4 is secreted by differentiated preadipocytes and adipocytes, with higher 
expression in larger adipocytes92. It has been recently shown that differentiated human 
adipocytes can promote adipogenesis via endogenous BMP-4 activation, a process that may 
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be counter-balanced by the expression of the BMP-4 (and -7) inhibitor gremlin-192. In 
hypertrophic obesity, adipose precursor cells are resistant to BMP-4, which may contribute 
to the limited expandability of adipose tissue and, subsequently, to obesity-related 
metabolic diseases92. 
Interestingly, adipose tissue has been very recently demonstrated as a major source 
of circulating microRNAs, and adipocyte-derived microRNAs could regulate gene expressions 
in liver in mice93, indicating that, aside the classical view that most of the adipokines are 
proteins, other factors like microRNAs might be considered as novel adipokines. 
 
 
Figure 8 : Adipocytes crosstalk with various organs through adipokines.  
 
Adopted from
94
. 
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2.4. Origins of white adipocytes 
Although adipose tissue development is poorly understood, the phenomenon that, in 
lipodystrophies, regionalized depot atrophy coexists with preservation and often expansion 
of other depots suggests that adipose tissue is an organ of multiple lineages95. In mice, it has 
been demonstrated that sWAT and vWAT form in an ordered and timed manner throughout 
embryogenesis and within the first few weeks of birth. sWAT begins to develop during 
embryogenesis and the compartment of progenitors is established for all the depots of 
sWAT before the first few days of life. Whereas, vWAT principally form postnatally: the 
perigonadal lineage forms approximately between postnatal day 3 and the second week of 
life. The mesenteric WAT adipose compartment completes its establishment of lineage 
between the second and third weeks of life. The retroperitoneal WAT is formed in-between 
these pre- and postnatal stages, and has a morphogenesis, texture, and histology that also 
seem intermediate96. Transcriptomic analysis of preadipocytes isolated from the SVF of 
various fat depots have revealed consistent differences in developmental gene profiles 
between vWAT and sWAT, indicating the possibility that sWAT and vWAT are of distinct 
origins 97. 
Three critical events are necessary for the establishment and maintenance of 
functional adipocytes (Figure 9): 
1) Determination of preadipocyte, commitment of multipotent progenitors into the 
adipocyte lineage. 
2) Adipocyte differentiation, in which committed preadipocytes undergo a 
morphological and biochemical transition into mature adipocytes in response to appropriate 
stumuli. 
3) Adipocyte maintenance, in which the cellular identity and functional properties if 
the terminally differentiated cells are maintained. 
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Figure 9 : Simplified scheme of white adipocyte origins. 
 
 
2.4.1. Adipocyte progenitor cells (APCs) 
Pluripotent stem cells, residing in the vascular stroma of adipose tissue, are able to 
be recruited into preadipocytes, which when appropriately induced, undergo mitotic clonal 
expansion and then differentiate into adipocytes (Figure 9). Adipocyte progenitor cells (APCs) 
reside in the SVF and could be separated from non-adipose precursors (e.g., endothelial 
progenitors, immune cell populations) using early adipocyte progenitor cells markers (Lin-: 
CD29+;CD34+;SCA1+:CD24+) with the technology of fluorescence-activated cell sorting 
(FACS), which could successfully proliferate and differentiate into WAT in A-Zip 
lipodystrophic transgenic mice98. 
To investigate the architecture of the stromal vascular (SV) compartment, Wei T., et 
al, developed an SV particulate (SVP) isolation procedure designed to partially maintain the 
native SV structure while removing adipocytes that obscure visualization of the precursor 
location. In the SVPs, the majority of peroxisome proliferator-activated receptor γ 
(PPARγ)/GFP cells were arrayed in tubelike structures, which immunohistochemically 
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expressed platelet endothelial cell adhesion molecule (PECAM) and mural cell markers: SMA 
(endogenous smooth muscle actin), PDGFRβ (platelet-derived growth factor receptor β), 
indicating that these adipocyte progenitors reside in the mural cell compartment of the 
adipose vasculature99. 
The large C2H2 zinc-finger transcription factor, Zfp423, is a factor associated with 
preadipocyte commitment. Zfp423GFP reporter mice show that Zfp423 distinguished 
adipogenic from inflammatory-like mural cells. Zfp423GFP expression was found not only in 
mature adipocytes but also in a distinct subset of perivascular cells expressing mural cell 
marker PDGFRβ, supporting the hypothesis that preadipocytes resemble pericyte-like cells. 
Upon high fat diet feeding, the frequency and absolute number of cells positive for GFP and 
Pdgfrβ significantly increase in gonadal WAT by comparision to inguinal WAT of male mice, 
consistent with the fact that gonadal WAT of adult mice expands by both adipocyte 
hypertrophy and adipocyte phyerplasia, while inguinal WAT expands predominantly through 
cellular hypertrophy70. 
Besides, adipocytes within different depots might have distinct progenitors. For 
example, the majority of the precursors and mature sWAT adipocytes in mice are labeled by 
paired related homeobox transcription factor 1 Cre (Prx1-Cre), while in contrast, few visceral 
adipocytes are marked by Prx1-cre100. Conversely, the wilms tumor gene (Wt1) expressing 
cells give rise to adipocytes in vWAT but not adipocytes in sWAT, and are enriched in the 
mesothelium, supporting that the lateral plate mesoderm as a major source of vWAT101. 
Multiple protein factors could increase the commitment of stem cells into 
preadipocytes. For example, following treatment of the C3H10T1/2 stem cells with bone 
morphogenic protein 4 (BMP4) during proliferation followed by differentiation inducers at 
growth arrest, the cells synchronously enter S phase and undergo mitotic clonal expansion, 
which is a hallmark of preadipocyte differentiation102. 
 
2.4.2. Adipogenesis 
During conversion of preadipocytes to adipocytes, preadipocytes employ a sequential 
induction of a series of transcription factors, including C/EBP families and PPARγ to express 
genes necessary for adipocyte function. They also undergo change in morphology to become 
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rounded lipid-laden adipocytes. In the 1990s, the nuclear hormone receptor PPARγ was 
identified as a master regulator of adipocyte differentiation. PPAR has three isoformes: 
PPARα, PPARδ, and PPARγ. PPARγ predominately cooperate with C/EBPα in the promotion 
of adipognesis103.C/EBPδ and C/EBPβ are induced early during adipognesis, peaking at day 2 
of adipogenesis and after decreased104.  The early upregulation of C/EBPδ and C/EBPβ 
facilitate the expression of PPARγ, and then PPARγ along with C/EBPβ and C/EBPδ activates 
C/EBPα expression. Chromatin immunoprecipitation (ChIP) study revealed that most induced 
genes in adipogenesis were bound by both PPARγ and C/EBPα. Thus, PPARγ and C/EBP 
factors cooperatively orchestrate adipocyte biology by adjacent binding, which activate 
hundreds of genes responsible for terminal adipocyte differentiation105. PPARγ can promote 
adipogenesis in C/EBPα-deficient cells. However, conversely, ectopic expression of C/EBPα 
could not stimulate adipognesis in PPARγ-deficient fibroblast, demonstrating that C/EBPα 
and PPARγ participate in a single pathway of fat cell development with PPARγ being the 
proximal effect of adipogenesis106. C/EBPα-deficient fibroblast underwent adipogenesis via 
activation of PPARγ with several apparent defects, including impaired insulin stimulated 
glucose uptake secondary to reduced gene expression and tyrosine phosphorylation for the 
insulin receptorand IRS-1. Later it was demonstrated that insulin receptor promoter or 
enhancer was preferentially transactivated by C/EBPα107. 
Signal transducer and activator of transcription 3 (STAT3) was reported to be 
activated by Janus kinase 2 (JAK2) within 2h of adipogenesis induciotn on 3T3-L1 adipocytes, 
translocating from cytoplasm to the nucleus and regulating the transcription of C/EBPβ by 
binding the distal region of its promoter108 (Figure 9). 
PRDM16 is more enriched in sWAT compared to that in vWAT in mice, associated 
with its role in the development and function of beige cells. Ablation of PRDM16 caused a 
switch of sWAT to vWAT like phenotype, and impairment of thermogenic gene expression in 
response to cold exposure, indicating that PRDM16 pathway is necessary for the 
differentiation of brite adipocytes9. In human, the elevated levels of BMP4 in WAT 
correlated with a lean phenotype. Forced expression of BMP4 in mice induced a brown fat-
like alterations in WAT through upregulation of mitochondrial biogenesis in association with 
increased energy expenditure and insulin sensitivity, which is mediated by the PGC1α/ 
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p38/MAPK/ATF2 pathway109, indicating a potential role of BMP4 in the biogenesis of brite 
adipocytes (Figure 9). 
Wnts are a family of paracrine and autocrine factors that regulate cell growth and cell 
fate. Signaling is initiated when Wnt ligands bind to transmembrane receptors of the Frizzled 
family, which signals through Dishevelled to inhibit the kinase activity of a complex 
containing glycogen synthase kinase 3 (GSK3), Axin, β-catenin, etc. This complex targets β-
catenin for rapid degradation through phosphorylation. Thus, once hypophosphorylated due 
to Wnt signaling, β-catenin is stabilized and translocate to the nucleus where it binds the 
TCF/LEF family of transcription factors to regulate the expression of Wnt target genes. When 
Wnt signaling was activated in 3T3-L1 or 3T3-F442A, adipogenesis was significantly impaired, 
with no alterations in the expressions of C/EBPδ and C/EBPβ, but decreased levels of C/EBPα 
and PPARγ. Consistently, over-expression of C/EBPα and PPARγ could partly rescue the 
impaired adipogenesis due to Wnt activation110 (Figure 9). 
Pref-1 is a transmembrane protein encoded by the pref-1/dlk1 gene and belongs to a 
family of EGF-like repeat-containing proteins that include Notch/Delta/Serrate, which are 
involved in cell fate determination.Interestingly, Pref-1 is highly expressed in 3T3-L1 
preadipocytes, but almost abolished in adipocytes111. The extracellular domain of Pref-1 
undergoes two proteolytic cleavage events that generate 50 and 25 kDa soluble products. By 
fusing Pref-1 to human immunoglobulin-γ constant region (Pref-1/hFc), transgenic mice 
expressing the Pref-1/hFc transgene under the aP2 promoter, showed reduced expression of 
adipocyte markers and adipokines, whereas the preadipocyte markers Pref-1 was increased. 
Moreover, mice expressing the Pref-1/hFc transgene exclusively in liver under the control of 
the albumin promoter also showed a decrease in adipose mass and markers, suggesting an 
endocrine role of Pref-1 on adipogenesis112 (Figure 9). 
The seven Sirtuins in mammals (Sirt1-Sirt7), which are involved in the regulation of 
several essential cellular processes, also have important roles in adipogenesis. Sirtuin 1 (Sirt 
1) is the ortholog of the yeast protein silent information regulator 2 (Sir2) and a nuclear 
NAD+-dependent class III histone deacetylase class III, and is a key component activated by 
CR. Sirt 1 partly mediated the inhibitory effects of CR on adiposity by attenuating 
adipogenesis through suppressing PPARγ by docking with its cofactors NCoR (nuclear 
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receptor corepressor) and SMART (silencing mediator of retinoid and thyroid hormone 
receptors). Conversely, Sirt7 which is known to specifically deacetylate H3K18, is reported to 
promote adipogenesis by binding and repressing Sirt1 activity113. The forkhead transcription 
factor FOXO1 is an important downstream effector of insulin/PI3K/AKT signaling, which lead 
to its phosphorylation and thereby nuclear exclusion. Constitutively active FOXO1 
attenuated adipogenesis, while dominant-negative FOXO1 restored adipogenesis of 
fibroblasts from insulin receptor deficient mice114. Interestingly, mammalian Sirt2 is localized 
mainly in the cytoplasm and is reported to be down regulated during adipogenesis, and its 
over-expression inhibits differentiation via enhancing insulin-stimulated phosphorylation of 
FOXO1115. 
3. Alterations of WAT by aging 
Over the last decades, the growing number of elderlies (aged 65 years and over) has 
become a considerable challenge to health and social care service provision and funding. 
Moreover, the numbers of the very old, those aged 85 years and over, are set to double over 
the next 20 years116. Aging is defined as a decline in survival and fecundity with advancing 
age, which is caused by damage to macromolecules and tissues. 
What are the consequences of aging on WAT? 
In human, age per se is a strong risk factor for fat accumulation117. Morphologically, 
computational tomography scans in men and women revealed that, as age increases, sWAT 
decreases while vWAT increases118. Rodents also demonstrate the same trend to develop 
age-associated central obesity119. Consequently, the dramatic alterations in fat distributions 
and functions occurring during life, are linked with the increasing risks of the developments 
of various aging-associated diseases, such as diabetes, cognitive dysfunction and 
atherosclerosis120. Multi-isotope imaging mass spectrometry (MIMS) is an imaging method 
that enables multiplexed measurement of stable isotope tracers with subcellullar resolution, 
and utility of stable isotope tracers of DNA synthesis and DNL to measure cell birth and lipid 
turnover. It was demonstrated that there’s an age-dependent decline in the plasticity of 
adipose tissue whih is characterized by impaired adipogenesis and adipocyte lipid turnover 
in subcutaneous fat, which might be mediated by a decline in insulin like growth factor-1 
(IGF-1) in humans121. In addition, by measuring the 2nd World Warnuclear bomb test-derived 
33 
 
14C in lipids accumulated in adipocytes (in Hiroshima), it was reported that during the 
average ten-year-life span of human adipocytes, TG were renewed six times. Adipocyte lipid 
turnover is strongly related to conditions with disturbed lipid metabolism122. 
Therefore, in the following part, we will detail effects of aging on adipogenesis and 
lipid turnover, respectively. 
 
3.1. Senescence of adipocyte progenitors 
Compromised adipogenesis during aging contributed to the impaired ability of 
adipose tissue to store lipids, leading to FFAs spillover and ectopic lipid accumulation in liver 
or muscle123. Senescence of adipocyte progenitors mediates partly the impaired 
adipogenesis during aging. 
Senescence of adipocytes progenitors is increased in aged adipose tissue, 
demonstratd with upregulation of senescence-associated markers: SA-β-galactosidase and 
p16/p53 expressions124. 
The senescence burden could further accelerate age-related dysfucntions in fat via 
both intrinsic and autocrine manners125. For instance, senescent adipocyte progenitors 
would impede the adipogenesis of non-senescent cells, via the activation of the JAK/STAT 
and over production of the activin A protein126. 
Growth hormone (GH) plays a central role in regulating mammalian growth, 
metabolic homeostasis and adiposity. Both mice and human who have excessive GH 
production have increased mortality rates compared to age-matched counterparts 127. Ames 
and Snell dwarf mutant mice (Prop1df and Pit1dw, respectively) are the first GH-deficient 
genetic mutants to display extension of lifespan. Interestingly, deficiency of GH in Ames and 
Snell mice attenuated the age-related central accumulation of vWAT. Besides, the levels of 
senescent fat progenitors measured by p16 expressions or SA-β-galactosidase, were 
negatively associated with the levels of GH. Thus, attenuation of senescent burden in vWAT 
might mediate the life-extending effects of GH deficiency128. 
Clearance of senescent cells confers counteractions to age-related irregulations in 
adipocytes. For example, genetic clearance of p16 positive cells delayed or attenuated the 
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reduction of the volumes of adipocytes129. In addition, depletion of p53 ameliorated 
senescence like changes in Ay obese mice, associated with improved insulin resistance130. 
 
3.2. Altered lipid turnover 
As mentioned before, fat cells function to store cytotoxic lipids, for example FFAs into 
neutral LDs131. However, this lipid storage capacity of adipocytes is impaired by aging. In 26-
month-old B6D2F1 mice, the average size of vWAT adipocytes was dramatically smaller 
compared with those in the counterparts of 6-month-old animals, indicating of a disability of 
lipid handling for adipocytes with aging132. The situation could be further demonstrated by 
the fact that middle-aged mice of around 14 months exhibited greater susceptibility to the 
toxicity of high fat diet, gaining more weight and fat content compared to their 3-month-old 
littermate133. Furthermore, three days of high fat diet feeding specifically induced memory 
deficits and significant brain inflammation in the aged rats, possible owing the the spillover 
of FFAs in the brain in aged rats134. 
 
How could these dysregulations be explained? 
Reduced sensitivity to nutrient stimuli 
Age can drive insulin resistance in adipocytes. Both basal and insulin stimulated 
lipogenesis are reduced in isolated adipocytes from humans and rats by aging135. In humans, 
glucose-mediated glucose disposal and glucose transport is decreased by 30-35% in the 
elderly (64 ± 4 years) compared to the nonelderly (32 ± 4 years)136. 
The exact mechanisms regarding to age-related insulin resistance is not well 
understand, but might be related to the alteraed immune-environments in adipose tissue in 
aging. For example, an increase in the portion of regulatory T (Treg) cells is observed in 
vWAT of 11-month-old mice compared to 1-month-old mice. Both genetic and 
pharmacological depletion of Treg cells in fat help to improve metabolic state and insulin 
stimulated glucose uptake137. Besides, aging is associated with a chronic state of low-grade 
inflammation in WAT. This is likely due to the fact that vWAT is a major source of cytokines, 
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responsible mostly for the up-regulation of circulating levels of inflammatory and pro-
coagulant factors such as, thrombospondin-1, plasminogen activator inhibitors-1 and -2, 
(PAI-1/-2), in comparison to liver or kidney. Furthermore, levels of these genes exhibited an 
age-associated increase in vWAT138. 
Impaired breakdrown and oxidation of LDs 
- Lipolysis 
Fasting-induced levels of glycerol and FFAs release in visceral fat were significantly 
reduced in aged mice139, indicating a decreased efficiency of hydrolysis of TG in adipocytes 
during aging. Aging is associated with reduced expression of lipolytic genes such as HSL and  
ATGL in adipose tissue140. There is also a concerted decline in fatty acid reesterification 
(PEPCK: phosphoenolpyruvate carboxykinase) enzyme expression. This leads to reduced 
adipocyte’s ability to recycle FFAs from extracellular pool, in 24-month-old mice compared 
to young mice140. Age-related alterations in the functionality of macrophages also contribute 
to age-reduced lipolysis. Camell et al, demonstrated that aging up-regulate the Nod-like 
receptor 3 (NLRP3) inflammasome in adipose macrophages, which is a driving factor for the 
catabolism of noradrenaline by downregulating growth differentiation factor-3 and 
monoamine oxidase. Consequently, catecholamine-induced lipolysis is negatively influenced 
in aged vWAT and thereby leads to age-related central fat accumulation141. 
- Mitochondrial oxidation 
In humans, proteomic analysis of adipocyte mitochondria reveals global down-
regulation of the oxidative phosphorylation system (OXPHOS) components by aging 
process142, indicating dysfunction of mitochondria. Dysfunction of mitochondria, through 
various aspects, contributes to reduced efficiency of lipid turnover in visceral adipocytes. 
Concomitant with this notion, oxygen influx stimulated by a combination of succinate and 
octanoyl carnitine during mitochondrial respiration is around 30% lower in older visceral 
WAT in relative to young vWAT132. 
In the early stage of aging, mitochondrial abnormalities could be responsible for 
adipocyte enlargement in middle-aged mice. It has been reported that middle-age promote 
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hypoxia inducible factor 1α (HIF 1α) in adipocytes which, as a transcriptional factor, 
repressed cytochrome C oxidase 5b (COX5b) expression by binding to its proximal promoter. 
Reduced COX5b then inhibits complex IV assembly and impaires fatty acid oxidation then 
resulting in adipocyte enlargement143. In addition, reduction in β-oxidation could also lead to 
increased rates of FFA efflux out of cells in order to avoid toxic FFA buildup in the 
cytoplasm144. Moreover, adipocyte β-oxidation is also important in maintaining body 
temperature, since adipocyte specific CPT2 knockout leads to cold intolerance in mice145. 
This might be one of the reasons to the cold intolerance by aging. 
 
4. Contribution of WAT to aging 
Adipose tissue is at the nexus of mechanisms and pathways involved in longevity and 
genesis of age-related diseases by general mechanisms such as inflammation or metabolic 
dysfunction. It has been proven that genetic profiles of WAT may affect lifespan146. For 
instance, PPARγ signaling pathway is revealed as the most significantly enriched biological 
pathway within the aging sub-network. In agreement, two independent PPARγ knockout 
mice models (one lacks PPARγ ½ exclusively in WAT and the other lacks PPARγ2 in all tissues), 
exhibit severe lipodystrophy and remain insulin-resistant, both having a significant reduction 
in lifespan147. Under extreme conditions of adiposity depletion, e.g., lipodystrophy 
syndromes such as genetic Berardinelli-seipcongential generalized lipodystrophy (BSCL) or 
familial partial lipodystrophic syndromes (FPLD), patients are markedly short-lived, 
suggesting that malfunctions of adipose tissue affect life quality and longevity. 
4.1. Nutrition/age-associated obesity attenuates longevity 
 The link between excessive fat development and aging 
Obesity is defined by a body mass index over 30 (BMI, an indicator of body fat 
calculated by dividing a person’s weight in kilograms by their height in meter squared). 
Pooled analysis data of 20 prospective studies from the United States, Sweden and Australia, 
reveal that people with Class III obesity (BMI> 40 kg/m2) have a dramatic reduction in life 
expectancy compared with people of normal weight, with most of the excess death due to 
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heart diseases, cancers and diabetes148. Interestingly, a strong correlation between high BMI 
and the “epigenetic age” of liver in human exists, which might help to explain why obese 
people suffer from the early-onset of many age-related pathologies, such as liver cancer149. 
Indeed, the group of Steve Horvath has recently developped a biomarker of aging 
(“epigenetic clock”) based on DNA methylation (DNAm) levels150, which is defined as a 
prediction method of chronological age based on the DNAm levels of 353 CpGs, also referred 
to as “DNAm age”. The use of DNAm age could be seen as a proxy of epigenetic tissue age. 
Finally, obesity has been shown to induce DNA damage in adipose tissue via activation of 
p53 pathway151. Moreover, disorders derived from energy metabolism might also negatively 
influence age-related pathogenesis. For example, Alzeihmer’s diseases patients are very 
often characterized by visceral fat accumulation, insulin resistance and abnormal secretion 
of leptin and adiponectin152. 
 Age and adipose tissue 
Besides the nutrition-induced obesity, age-related central obesity, which is accounted 
mainly by fat accumulation in visceral depot, is also negatively associated with insulin 
sensistivity. Different studies showed that aging per se does not drive this phenomenon, but 
it’s rather the augmented visceral fat during aging that is truly responsible for this age-
related insulin resistance153. Independently of other depots, vWAT plays an important role in 
modulating hepatic insulin action154. One of the most distinguished features of vWAT is that 
it is believed to be a source of harmful peptides such as resistin, PAI-1 and angiotensinogen, 
which might contribute to various pathological states in peripherical organs155. For instance, 
aging induces cardiac structural and functional changes associated with increased deposition 
of ECM proteins, such as osteopontin (OPN), resulting in progressive interstitial fibrosis. 
Visceral WAT strongly mediate this process156.  Indeed, it has been demonstrated that 
plasma OPN is increased in mice during aging, with vWAT showing the strongest OPN 
production in contrast to myocardium that does not express this protein. Moreover, vWAT 
removal or OPN inhibition greatly reverses senescence in cardiac fibroblasts156. 
Noticeably, not only the quantity but also the quality of fat mass matters. The 
epigenetic marker H3K4me3 is remodeled during aging and cellular senescence in mammals 
157. In paradox, the depletion of H3K4me3 methyltransferase (the COMPASS chromatin 
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complex) in Caenorhabditis elegans (C. elegans) promotes lifespan as well as fat 
accumulation accounted by specific enrichment of mono-unsaturated fatty acids (MUFAs). 
Moreover, dietary MUFAs are sufficient to extend lifespan158. These data suggest that not 
only the amount of fat but also the characteristics of the fat influence longevity. Indeed, the 
fatty acid composition of TG in visceral WAT is altered during aging in rats, with a marked 
decrease in shorter long-chain saturated fatty acids, whereas the levels of linoleic and oleic 
acids increase159. In addition, there are increases in the levels of total ether-
phosphatidylcholine, sphingomyelin, and free cholesterol in the lipid composition of 
adipocyte plasma membrane, which favor an enlarged cell size with aging159. Therefore, it 
remains interesting to investigate how the composition of adipocyte fatty acids alters during 
aging in various fat depots and what are the effects of different fatty acids on longevity. 
4.2. Removal or mobilization of vWAT increases longevity 
Due to the notorious associations of vWAT with age-associated pathologies, it has 
been proposed that surgical removal or stimulation of lipid mobilization might exhibit 
positive actions on life extension-associated benefits. On one hand, Radhika M. et al 
demonstrat that removal of vWAT in 5-month-old mice increases the mean and maximum 
lifespan and reduces the incidence of severe renal diseases compared to sham control mice 
160. On the other hand, in C. elegans, fat mobilization activation through the endocrine axis, 
which consists of nuclear translocation of the forkhead transcription factor DAF-16 (the 
equivalent of mammalian FOXO3a) and subsequent activation of the k04a8.5 lipase, 
mediates the prolonged longevity of germline stem cell arrest. Constitutive expression of 
this lipase in fat storage tissue generates lean and long-lived animals161. In a conserved 
manner, over-expression of dFOXO in the adult fruitfly (D. melanogaster) fat body, which is 
fly equivalent of mammalian liver and adipose tissue, increases longevity and reduces 
fecundity of females162. 
Since the FOXO is downstream and inactivated by the insulin/insulin-like growth 
factor (IGF) signaling in diverse organisms, these data suggest that attenuation of certain 
signaling pathways in fat might be associated with life-span extension. In addition, in D. 
melanogaster, limited activation of dFOXO in the fat body increases lifespan, while 
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repressing the synthesis of insulin-like peptide dilp-2 in neurons which then inhibites 
endogenous insulin-dependent signaling in peripheral fat body163. These findings suggest 
that insulin/IGF pathway in the adipose tissue could contribute to the control of aging 
through both autonomous and non-autonomous manners.  
This relationship has also been demonstrated in the mammals. Mouse animal models 
with reduced growth hormone (GH) and/or IGF-1 signaling have been shown to have an 
extended lifespan, the action of which is partly associated with a delayed increase in the 
ratio of visceral to subcutaneous fat, and most likely a reduced fat cell progenitor turnover164. 
Likewise, reduced dietary methionine intake prolongs lifespan in male Fish 344 rats, with 
reduced serum levels of lipids and IGF-1 as well as reduction in vWAT and increased energy 
expenditure165. Cre-Lox specific adipocyte depletion of insulin receptor protects mice from 
age-associated obesity and glucose response impairment, accounted mostly by an increase 
in small adipocyte populations less than 75µm166,167. Moreover, inducible knockout of insulin 
receptor in mice of median life-span extends the life span of these animals by 3.5 months 
and is associated with dramatic reduction in adiposity without alterations in food intake167. 
Interestingly, mice deficient for vasohibin-1, a protein originally isolated as an endothelium-
derived angiogenesis inhibitor and a stress tolerance promoter in endothelial cells, have 
improved longevity. Although the exact molecular mechanisms remain elusive, the 
attenuated levels of IR and IRS-1 in WAT levels might contribute to the life extending effects 
of vasohibin-1 deficiency168. 
There are also other molecules/mechanisms in WAT that contribute to life span. Sirt1 
(Sirtuin 1) is a member of the NAD+-dependent deacetylase family that catalyze the removal 
of acetyl groups from protein substrates. Mammalian Sirt1 acts as an energy and stress 
sensor modulating metabolic responses to nutrient availability. Selective over-expression of 
wild type human Sirt1 (AWSM) in adipose tissue in mice significantly prevents aging-
associated insulin resistance and improves systemic energy homeostasis as well as enhanced 
spontaneous locomotory activity, which could be attributed to the promotion of lipid 
metabolism in adipose tissue and muscle169. Increased mitochondrial oxidation in adipocytes 
also inhibits aging and diet associated-obesity in TFAMlx/lx/ adiponectin-Cre mice. Indeed, 
TFAM (mitochondrial transcription factor A) depletion in adipocytes results in an increased 
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electron transport chain flux and a greater fat glucose oxidation due to complex I and IV 
deficiency170. Conversely, in WAT, in vivo adipocyte specific knockout of acyl-CoA synthetase, 
which mediates conversion of FAs to acyl-CoAs, the limited step for FA metabolism, results in 
increased adipocyte volumes and cold intolerance in mice via an impaired β-oxidaition in 
WAT, which is a hallmark of aging171. 
Additionally, female mice deficient for diacylglycerol acyltransferase 1 (DGAT1), an 
enzyme that catalyzes the synthesis of TG, are protected from age-related fat accumulation, 
tissue TG accumulation as well as inflammation in WAT, which is accompanied with both 
increased mean and maximal lifespan. Moreover, these mice exhibit several longevity-
associated features, such as decreased levels of circulating IGF1172. 
Finally, in 2014, it was reported that FAT10 knockout mice had an extended lifespan 
in both female and male mice, associated with prevention of the age-associated obesity as 
well as metabolic dysfunctions173. The HLA-F adjacent transcript 10 (FAT10) is a member of 
the ubiquitin-like gene family that alters protein function/stability through covalent ligation. 
 
4.3. Novel insights from microRNAs 
While previous studies mainly focus on the nutrient sensing pathways in fat to 
lifespan, it has recently been reported that the abundance of microRNAs in adipose tissue is 
an important determinant of longevity. The biogenetic enzyme for microRNAs: dicer is 
decreased in sWAT during aging. On the contrary, overexpression of this enzyme in the 
intestine of C. elegans, increases the lifespan as well as resistance to heat shock and 
oxidative stress174. MicroRNAs from fat can play important roles in both cell autonomous 
and non-autonomous manners. For instance, mir-8 knockout drosophila exhibits a smaller 
body size compared to control drosophila, which could be rescued by its conditional 
overexpression in fat, which then leads to derepression of USH, an inhibitor of PI3K p85a 
subunit175. This result then raises the question why PI3K inhibition in fat can lead to systemic 
effects, highlighting the endocrinal role of adipose tissue. For example, improved circulating 
profile of adipokines, e.g., reduced levels of leptin, TNF , IL-6 or C-reactive protein might 
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mediate the cardio-protective effects of intermittent fasting and caloric restriction in 
human176. 
However, the precise molecular pathways that microRNAs in adipose tissue employ 
to achieve those benefits, remain to be largely unclear. 
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PART II: MicroRNAs in white adipose tissue 
1. Biogenesis and regulation of microRNAs 
1.1. Biogenesis of microRNAs 
MicroRNAs (miRNAs) are a family of small non-coding RNAs that post-
transcriptionally regulates mRNAs levels or stability by pairing to the 3’-untranslated regions 
(UTR) of their targets. In 1993, Ambros et al discovered the first miRNA, lin-4 in C.elegans, 
which was identified as a small non-coding RNA regulating the expression of the protein lin-
14177. Several years later, let-7, another famous miRNA was discovered in C. elegans, 
negatively regulating the expression of the gene lin-41 via RNA-RNA interactions with the 3’-
UTR of lin-41178. Subsequent reports further unveiled that miRNAs were abundant in both 
invertebrates and vertebrates, with some are highly conserved, suggesting that miRNA-
mediated gene regulation is a general regulatory function across species179,180. Currently, 
there are up to 1872 annotated human miRNA precursor genes that are processed into 
around 2578 mature miRNA sequences (http://www.mirbase.org) with functions of lots of 
them are waiting to be clarified. 
Biogenesis of miRNAs starts with transcribing genes into large primary transcript (pri-
miRNAs), which is 5’ capped and 3’ polyadenylated in structure. The transcription is typically 
mediated by RNA polymerase II181,182. The pri-miRNAs are then cleaved by a microprocessor 
complex, consisting of the type III RNase Drosha and RNA-binding protein DGCR8, into an 
around 85 nucleotides stem-loop structure named precursor miRNA (pre-miRNA). Following 
transportation by Ran/GTP/Exportin 5 complex from nucleus to cytoplasm, the pre-miRNAs 
are processed by the RNase III enzyme Dicer to an around 20-22- nucleotide miRNA/miRNA* 
duplex (note: * indicates the passenger strand, while the other complementary strand is 
referred as the mature or guide strand). 
After the duplex is unwound, mature miRNAs are incorporated into a protein 
complex termed RNA-induced silencing complex (RISC) and guide RISC to target mRNAs 
(Figure 10)177,178. In many cases, miRNA-target interactions are mediated by the seed region, 
a 6- to 8-nucleotide-long fragment at the 5’-end of the miRNA that forms Watson-Crick pairs 
with the cognate target183. Inside RISC, once binding to their target miRNAs, miRNAs would 
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result in translational repression if imperfect complementarity, or target mRNA degradation 
if perfect complementarirty184. 
The biogenesis of miRNAs is under tight control at multiple levels, including the levels 
of miRNA transcription, processing by Drosha and Dicer, transportation, RISC binding and 
miRNA decay. For example, the KH-type splicing regulatory protein (KSRP), serves as a 
component of both Drosha and Dicer complexes to regulate the biogenesis of a subset of 
miRNAs in mammalian cells55. 
 
Figure 10: The classical pathway of microRNA biogenesis.  
Adopted from
185
. 
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1.2. Regulation of miRNAs expression in adipose tissue 
Expression of miRNAs in adipose tissue could be regulated via several mechanisms. 
With the next generation sequencing technology, it has been reported that for a majority of 
miRNAs in adipose tissue, genetic regulation of expression was independent of the 
expression of the mRNA from which this miRNA is transcribed. Moreover, the degree of 
genetic variation of miRNA expression was substantially less than that of the mRNA186. 
However, expression of some miRNAs is highly correlated with the mRNA from which the 
miRNAs are transcripted from. For instance, mir-378 resides in the sense strand of the first 
intron of PGC-1β, which is a transcriptional co-activator that regulates mitochondrial 
biogenesis. Similar to PGC-1β, mir-378 was also identified as key regulatory component 
underlying the biogenesis of mitochondria in adipose tissue187. 
On the other hand, expression of some miRNAs in adipose tissue could be regulated 
directly through alterations in their promoters. For example, NF-κB stimulation in 3T3 
adipocytes resulted in inhibition of PPARγ transcription, with miR-130 participating in this 
process.  Chromatin immunoprecipitation (ChIP) assay demonstrated that activation of NF-
κB pathway by TNFα induced increased binding of p65 to the promoters of both mir-130a 
and mir-130b. Deletion of these two miRNAs could partly block the inhibition of PPARγ by 
TNFα188. Similary, NF-κB would directly bound to the promoter of mir-1275 and inhibited its 
transcription in human mature adipocytes189. Glucocorticoids (GCs) could transcriptionally 
regulate the expression of miR-19b via a GC receptor-mediated binding to its promoter and 
significantly enhance its expression190. 
Still, for most of miRNAs, how their expressions are regulated in adipose tissue 
remain to be investigated. For example, the expression of mir-21 in human adipocytes was 
elevated following inflammatory stimulators such as TNFα, IL-6, leptin or FFAs191. Mir-224-5p 
was elevated in 3T3 adipocytes upon TNFα treatment. Knock down of mir-2224 suppressed 
NF-κB activation and rendered adipocytes susceptible to apoptosis192. The exact mechanisms 
regarding these alterations remain to be investigated. 
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2. MiRNAs in the formation of adipose tissue 
2.1. MiRNAs in differentiation of adipocytes progenitors 
Adipogenesis is under tight regulations of various miRNAs in both mice and 
humans.Adipocyte dicer depletion resulted in extreme low adiposity due to depleted WAT193. 
Since the fat mass is mainly determined by the number and the volume of adipocytes, it 
indicates that the loss of certain miRNAs due to dicer deficiency could have a role in 
adipogenesis or lipid homeostasis in adipocytes which lead to a loss fat mass. Subsequently, 
numerous evidence sare surging concerning various miRNAs affecting adipogenesis, via 
targeting classic components involved in adipogenic program. Here, we will review reported 
individual miRNA that exhibits either pro-or anti- effects on adipogenesis which are listed in 
Table 2. 
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Table 2: List of miRNAs involved in adipogenesis 
miRNAs Model of 
adipogenesis 
Targets/mechanisms Pro/anti-
adipogenesis 
Reference 
Mir-143-3p ADSC Repressing MAP2K5 Dual 194 
Mir-15a/b Porcine 
preadipocytes 
Repressing FOXO1 Pro 195 
Mir-17-92 cluster 3T3-L1 Down-regulating Rb2/p130 Pro 196 
Mir-30a/d hMADS Inhibition of the osteogenesis 
TR RUNX2 
Pro 
 
197 
Mir-30c hMADS Targeting PAI-1 and ALK2 Pro 198 
Mir-103 3T3-L1 Targeting MEF2D and 
activation of AKT/mTOR 
Pro 199 
Mir-17-5p/mir-
106a 
hMADS Suppressing osteogenesis via 
BMP2 
Pro 
 
200 
 
Mir-146b 3T3-L1 Targeting the 3’ UTR of SIRT1 
and induced acetylation of 
FOXO1 
Pro 201 
 
Mir-342-3p Human adipose-
derived MSCs 
Releasing C/EBPα from 
Binding with CtBP2 
Pro 202 
Mir-355 Ob/ob, db/db, KKAy 
mice 
Levels in WAT correlated with 
body weight and adipocyte 
differentiation markers 
Pro 203 
Mir-455 3T3-L1 Targeting UCP1 Pro 204 
Let-7 3T3-L1 Induction during 
differentiation, 
Unclear 
Anti 205 
Mir-27a 3T3-L1 Suppressing PPARγ 
expression via 3’ UTR 
Anti 206 
Mir-27b Zebrafish/ 3T3-L1 Negatively correlated with 
the levels of as PPARγ, 
C/EBPα and SREBP-1c. 
Anti 207,208 
Mir-29a/b/c 3T3-L1 Targeting DNA Anti 209 
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methyltransferase DNMT3A 
Mir-33b Human primary 
adipocytes 
Induced during human 
adipocytes differentiation 
targeting HMGA2 and cyclin-
dependent kinase 6 
Anti 210 
Mir-93 Lentivirus injection 
in visceral fat in 
mice/ 3T3-L1/ mir-
25-93-106b-/- mice 
Negatively regulating Sirt7 
and TBX3 
Anti 211 
Mir-125a-5p 3T3-L1 Negatively regulating STAT3 Anti 212 
Mir-130 Human primary 
adipocytes 
PPARγ Anti 
 
213 
Mir-155 3T3-L1 Induced by tnfa via the NF-κB 
pathway and targeting 
targeting C/EBPβ and CREB 
Anti 214 
Mir-1275 Human visceral pre-
adipocyte 
Targeting and silencing of 
ELK1, an E-twenty-six-domain 
transcription factor 
Anti 215 
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2.2. Determination of adipocytes identities 
Different fat depots have distinctive characteristics and functions. Although precise 
mechanisms determining the fat distribution remain largely unknown, differential 
expressions of miRNAs amongst various fat depots might be involved. Interestingly, 
adipocytes dicer deficiency leads to partial lipodystrophy, with a dramatic decrease in 
epididymal fat but a significant increase in BAT, the situation of which would be further 
exacerbated by high fat diet exposure216. Similarly, adipocyte -specific DGCR8 knockout mice 
display shrinked WAT with decreased specific gene markers and tolerance in response to 
cold exposure217. The group of Steven R.S. finds that mir-196a is differentially expressed in 
gluteofemoral and in subcutaneous abdominal fat in humans, with its level more abundant 
in adipocytes of the gluteofemoral region218. The favorably expressed mir-196a in 
gluteofemoral adipocyte might negatively regulate the homebox (HOX) family genes, which 
are involved in the transcriptional regulation of adipogenesis and less abundant in 
gluteofemoral fat218. These results indicate that the abundance of mature miRNAs is vital in 
the determination and maintenance of identities of different adipocytes, and linked to their 
intrinsic properties and functions. 
 The transcriptomes of miRNAs in sWAT and vWAT differ from 
each other219. 
MirRNAs enriched in sWAT are mainly related to adipogenesis and lipid metabolism. 
For example, mir-155-5p, mir-143-5p, mir-27b-3p or mir-193b-3p and mir-365, all of which 
are summarized in (Table 2) above, are amongst those miRNAs enriched in sWAT. 
In contrast, the vast majority of miRNAs enriched in vWAT are associated with 
inflammation. For example, mir-145 is attenuated in the omental adipose tissue of obese 
patients and is proposed to improve macrophage-mediated inflammation by targeting ADP-
ribosylation factor 6 (ARF6)220. In human adipose tissue, mir-99a expression is negatively 
correlated with inflammation, possibly regulating macrophage  phenotype-switching by 
targeting TNFα221. Finally, let-7 family is strongly associated with fat mass and systemic 
glucose tolerance222. Additionally, a group of vWAT-enriched miRNAs are found to be 
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involved in various pathologies. For instance, mir-125a is down regulated in adipose tissue 
by fat diet in mice or in obese patients and in in vitro insulin-resistant 3T3-L1 adipocytes223. 
Similarly, mir-103 is associated with insulin sensitivity in adpocytes224. 
 MiRNAs mediate the metabolic flexibility of adipose tissue. 
As mentioned before, human subcutaneous fat is capable of substantial metabolic 
flexibility, such as acquiring features of brown fat in response to stimuli of cold exposure, β-
adrengic receptor or PPARγ agonists, associated with increased mitochondria biogenesis and 
UCP1 expression. MiRNAs are necessary for this identity switch. 
Indeed, mir-30a-5p, which is less expressed in subcutaneous fat compared to its level 
in BAT and inversely associates with the level of ubiquitin carrier protein 9 (UCP9) between 
these two fat depots, would result in browning program in human white adipocytes: 
mitochondrial biogenesis and brown transcription factors expression via targeting and 
inhibiting UCP9225. In vitro, forced expression of mir-30b/c significantly increases 
thermogenic gene expressions and mitochondrial respiration in primary adipocytes from 
sWAT, by targeting the 3’UTR of the receptor-interacting protein 140 (RIP140)226. Conversely, 
let-7i-5p is decreased in brite adipocytes in sWAT and injection of let-7i-5p mimic into sWAT 
in mice partially inhibits the β3-adrenergic activaton of the browning process227. Similarly, 
mir-125b-5p level is reduced in sWAT upon β3-adrenergic receptor stimulation, with 
injection of mir-125b-5p mimic directly into WAT inhibiting β3-adrenoceptor-mediated 
induction of UCP1 and mitochondriogenesis228. 
Further results demonstrate that the thermogenic gene program of PPARγ /PRDM16 
in sWAT is under the control of miRNAs: mir-30a-5p affecting PPARγ/PRDM16 via targeting 
the E2 SUMO ligase UBC9 in sWAT, a factor repressing acquisition of brown fat features in 
human adipocytes 225; mir-133a (mir-133a1/a2) directly targeting the 3’ UTR of PRDM16, 
with mir-133 depletion in mice increasing UCP1 expression and browning of sWAT229. 
Aside from beiging, subcutaneous fat could also acquire a visceral-like feature under 
certain conditions. For instance, 24-h fasting induces “visceralization” of sWAT in young mice, 
possibly accounted by a reduction in PRDM16 due to the upregulation of mir-149-3p in the 
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fat depot230. Therefore, it remains interesting to investigate whether mir-149-3p is a vWAT 
enriched miRNA. 
 
 
2.3. Involvement in adipose tissue functions 
MiRNAs expression in human adipose tissue is fat-depot specific and related to 
parameters of obesity, fat distribution, glucose metabolism and adipose tissue 
morphology231. 
 MiRNAs in lipolysis 
In demand of nutrients deprivation, such as fasting or exercise, TG in adipocytes are 
hydrolyzed to release fatty acids to support other organs57. 
KSRP is a multifunctional RNA-binding protein involved in the posttranscriptional 
regulation of gene expressions, and is also important for pri-miRNA processing232. KSRP 
deletion is associated with increased lipolysis in adipose tissue, accompanied with the 
impaired processing of pri-miR-145 into mature mir-145, which directly targets pro-lipolytic 
genes: CGI58 and FOXO1233. Mir-277 depletion results in severe impairment in lipid storage 
in female mosquitoes, associated with cytoplasmic retention of FOXO, arguing a role of mir-
277 depletion in the promotion of lipolysis via FOXO234. Moreover, the expression of mir-
124a is inversely correlated with the level of ATGL and its coactivator CGI-58 in various 
murine tissues such as adipose tissue and liver. In addition, ectopic expression of mir-124a 
leads to lipolysis inhibition which could be rescued by expressing mutant ATGL lacking its 
3’UTR235. 
In parallel, insulin signaling pathway is crucial for the various processes like glucose 
uptake and lipogenesis in adipocytes236. Abnormality of insulin signaling in obesity or over 
nutrition has been reported to be associated with irregularities of miRNAs levels237. 
 MiRNAs in insulin-stimulated glucose uptake in adipose tissue 
Some miRNAs are positively associated with insulin-stimulated glucose uptake.  
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For example, mir-26b is reduced in vWAT in obese rodents, human obesity and 
insulin resistant adipocytes, and is negatively correlated with BMI or HOMA-IR (homeostatic 
model assessment for insulin resistance). In vitro studies with differentiated human 
adipocytes suggest that mir-26b could promote insulin-stimulated glucose uptake via 
increasing GLUT4 translocation onto the plasma membrane via inhibition of the phosphatase 
and tensin homologue (PTEN), which is an antagonist of PI3K signaling238. 
 
Some miRNAs are negatively associated with insulin-stimulated glucose uptake.  
Mir-223 is increased in the adipose tissue of women with insulin resistance and is 
positively associated with HOMA-IR. Overexpression of mir-223 in human adipocytes directly 
reduces protein levels of GLUT4 and blocks insulin stimulated glucose uptake239. Likewise, 
mir-93 is up-regulated in the adipose tissue of women with insulin resistance as well as 
polycystic ovary syndrome patients (approximately 70% of who have intrinsic insulin 
resistance), correlating reversely with GLUT4 level and positively with HOMA-IR240. The 
mimic of mir-146b is directly transfected into porcine primary adipocytes, leading to 
impaired glucose uptake due to its inhibitory effect on IRS1 and GLUT4 expressions241. 
MiRNAs are found to be vital mediators of the obesity associated insulin resistance in 
adipose tissue. For example, in the context of obesity or diabetes in mice, mir-103 and mir-
107 are elevated, while their silencing through systemic injection of its inhibitor significantly 
reduces adipocyte sizes and restores systemic glucose tolerance, arguing for a role of these 
two miRNAs in insulin resistance. Mechanical study reveals that caveolin-1, the principal 
protein of caveolae, a structure on the plasma membrane of adipocytes associated with 
insulin receptor stability, is a direct target of mir-103/mir-107224. 
Mir-377 is increased in visceral fat in mice by high fat diet and impairs insulin 
stimulated AKT phosphorylation via suppression of SIRT1, which improves insulin sensitivity 
by repressing protein tyrosine phosphatase (PTP1B)242. Similarly, mir-221 could also target 
SIRT1 and contribute to insulin resistance in WAT by high fat diet induced obesity243. 
At the level of adipose tissue, adipose tissue macrophages (ATMs) infiltration in the 
context of obesity is a leading cause of the chronic inflammatory state in fat tissue, a strong 
contributor to insulin resistance. It has been reported that ATMs-derived mir-155 strongly 
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contributes to the impaired insulin stimulated glucose transport in adipocytes, possibly 
related to its direct suppression of the target gene PPARγ244. 
 MiRNAs in lipogenesis 
Various miRNAs could also modulate the sizes of adipocytes by targeting pathways 
related to lipogenesis. As an example, mir-192* is negatively correlated with serum TG and 
positively with high density lipoproteins (HDL) in morbidly obese subjects. In vitro 
experiments show that over expression of this miRNA in adipocytes, leads to a reduction in 
lipid storage accounted by inhibited expression of lipogenic enzymes such as stearoyl 
coenzyme A desaturase-1 (SCD-1) and aldehyde dehydrogenase 3 family memeber A2 
(ALDH3A2)245. 
Located in the first intron of PGC-1β, miR-378/378* are coorninately expressed 
during adipogenesis and expressed in the same tissues as PGC-1β. Overexpression of miR-
378/378* in 3T3 adipocytes leads to lipid accumulation associated with increased expression 
of lipogenic genes, such as C/EBPα and C/EBPβ246. 
In fat cells, mir-143-3p can increase insulin-stimulated lipogenesis, possibly related to 
the upregulation of protein kinase AMP-activated catalytic subunit α2 (PRKAA), which 
encodes a catalytic subunit of AMPK247. 
 MiRNAs in other aspects of adipocytes 
MiRNAs also participate in other aspects of adipocytes, such as apoptosis, 
inflammation response and energy expenditure process, etc. For instance, natural 
conjugated linoleic acids (CLAs) show strong anti-obesity actions in humans and animals, 
which could reduce the TG content of mature adiocytes and induce apoptosis. The 
expression of mir-23a is inhibited in adipose tissue in mice administrated with CLAs and its 
inhibition mediates the apoptotic action of CLAs on adipocytes via its direct effect on 
apoptotic protease-activating factor 1 (APAF1)248. Very recently, mir-103/107 have been 
identified to promote ER stress-mediated apoptosis by targeting the Wnt3a/β-catenin/ATF6 
(activating transcription factor-6) pathway in preadipocytes249. 
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The obesity associated mir-146a is found to dampen the inflammatory response in 
human adipocytes demonstrated by reducing phosphorylation of p38 and c-Jun N-terminal 
kinase (JNK) via targeting TNF receptor-associated factor 6 (TRAF6) and IL-1 receptor-
associated kinase 1 (IRAK1), which act downstream of the IL-1 receptor and toll-like 
receptors250. 
MiR-155-5p knockout prevents high fat diet induced adipocyte hypertrophy and 
weight gain, possibly owing to the increased energy expenditure251. Likewise, elevation of 
mir-34a in adipocytes from obese individuals252 inhibits the browning of adipose tissue partly 
by suppressing fibroblast growth factor (FGF21)/ SIRT1. In constrast, inhibition of mir-34a 
expression reduces high fat diet induced adiposity, associated with improved oxidative stress 
in mice253. 
 
3. Release from adipose tissue 
Besides being present and identified in tissues, miRNAs are also stable in the 
circulations with a large fraction of them found in exosomes254 (50-200 nm vesicles that are 
released from mutivesicular bodies)255. Since adipocytes are now well appreciated as a type 
of cell with endocrine functions and could secrete hundreds of bio-molecules, it is 
temptating to investigate whether adipocytes are able to secrete miRNAs and these secreted 
miRNAs can crosstalk with other cells or organs. In this context, it has been clearly 
demonstrated that adipose tissue is able to release extracellular vesicles (EVs). Indeed, 
adipose tissue derived extracellular vesicles (ADEV) include exosomes that are released by 
multivesicular bodies fusing with the cell membrane and mcirovesicles (100-1000 nm 
vesicles originated by shedding of the plasma membrane)256-258. Surprisingly, adipose tissue-
specific knockout of the miRNA-processing enzyme dicer (ADicer KO), results in a substantial 
decrease in most of the circulating exosomal miRNAs, which could be reversed by 
transplantation of adipose tissues from wild type mice, indicating that adipose tissue might 
even be a major source of systemic exosomal miRNAs93. 
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 Adipocytes-derived miRNAs as biomarkers 
Exosomal features of miRNAs could also be proposed as novel biomarkers. Treatment 
with cAMP substantially results in an approximately 5-fold increase in exosomes release 
from human brown adipocytes, containing more mir-92a insides, indicating that in response 
to different stimuli, fat could sort distinct individual or spectrum of miRNAs into exosomes 
for secretion259. Furthermore, with the study from a large cohort of humans, it has been 
demonstrated that exosomal mir-92a inversely correlates with human BAT activity measured 
by 18F-FDG PET/CT, suggesting that mir-92a represents a potential serum biomarker for BAT 
activity259. 
 Adipocytes-derived miRNAs are functional 
Then, aside from their presences in exosomes, are these miRNAs functional? Current 
literature supports this hypothesis. 
Under physiological state, adipose tissue extracts are shown to be able to promote 
adipogenesis, suggesting that adipose tissue could produce bioactive factors to regulate 
adipogenesis via paracrine signals260,261. In vitro studies have found that adipose tissue- 
derived exosomes-like vesicles could be internalized into adipose tissue-derived stem cells 
(ADSCs), and promote the adipogenesis of the cells via the pro-adipogenic miR-450a-5p 
which inhibits WSIP2 (WUS-interacting protein 2) expression262. 
In an endocrine view, FGF21 (fibroblast growth factor-21), produced by liver and 
other tissues, is elevated in blood and liver in ADicer KO mice, but could be reduced by 
injection of wild type exosomes. Moreover, in vitro, exosomes isolated from ADicer KO 
exhibit a less inhibitory effect on FGF21-3’UTR luciferase activity compared to those isolated 
from wild-type mice93. These data indicate that adipocytes-derived miRNAs regulate FGF21 
expression in liver. Pathologically, in response to high fat diet, adipocyte-derived mir-155 can 
be uptaken by macropahges, leading to M1 macrophage polarization263. Another study also 
elegantly demonstrates that miRNAs can mediate crosstalk between adipocytes and 
peripherical cells. One of the side effects of rosiglitazone (RSG) treatment is cardiac 
hypertrophy264,265, which is also a same case in mice lacking PPARγ specifically in 
cardiomyocytes264,265. This phenomenon indicates that PPARγ activation in noncardiac 
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tissues might contribute to the cardiac hypertrophy. Interestingly, Xi Feng et al reported that 
PPARγ activation in adipocytes by RSG increases the content of mir-200a in adipocyte-
derived exosomes, which then causes mTOR activation and hypertrophy in 
cardiomyocytes266. Therefore, adipocyte-derived mir-200a might mediate the hypertrophic 
effects of RSG in heart. 
Although it has been reported that exosomes might be secreted in a ceramide-
dependent manner 267, the exact mechanisms underlying the regulation of exosomes release 
and miRNAs sorting into exosomes remain largely unknown and worthy of further 
investigation. 
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PART III: MiRNAs in aging 
1. Dysregulations of miRNAs in aging 
Molecular changes during the aging process are crucial to better understand the 
mechanisms of age-related diseases, such as cancer, cardiovascular, neurogenegerative and 
immunological diseases as well as diabetes, etc. Specific molecules such as telomerase, 
p16INK4A, mTOR, NF-κB1 and SIRT1 have been found to be involved in the aging process, and 
have been used as predictors of longevity268-271. Recently, mounting evidences have 
suggested that miRNAs are also crucial determinants of the longevity of the organisms. For 
instance, the preservation of biogenesis of miRNAs is shown to be vital for the life-extending 
effects of metaformin.  By activation of AMPK pathway, metformin alters the subcellular 
localization of the RBPAU- rich element-binding factor 1 (AUF1), disrupting its interaction 
with Dicer1 and protects it from being degraded by AUF1272. Therefore, study of miRNAs’ 
involvement in aging, might provide new insights and pharmaceutical targets for healthy 
aging. 
Currently, plenty of miRNAs have identified to be involved in aging as well as age-
related diseases. 
 
1.1. MiRNAs involved in overall longevity 
Evidence from C. elegans revealed that miRNA biogenesis genes are highly 
networked with transcription factors and aging-associated miRNAs. For instance, mir-71 is 
upregulated during aging, repressing ALG-1/AGO expression post-transcriptionally. Reversely, 
mir-71 loss of function leads to increased ALG-1 expression followed by a widespread mRNA 
expression dysregulations. Thus, the progressive molecular decline often thought to be the 
result of accumulated damage over an organism’s lifespan, may be partially explained by a 
miRNA-directed mechanism of age-associated decline273. Additionally, Christopher et al 
investigated the liver transcriptome changes in mice model of dietary plus lifestyle 
interventions that modify aging-related phenotypes. By high-throughput deep sequencing, 
they found a significant larger proportion to have decreased expressions of miRNAs with 
longer lifespan. Furthermore, they experimentally validated mir-34a, mir-107 and mir-212-
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3p targeted the chromatin remodeler CHD1, knockdown of which mimic high-fat diet and 
aging induced gene expression profiles274. 
Currently, considerable attention has been devoted to age-associated changes in 
individual miRNA, which later is demonstrated to be critical in the regulation of mammalian 
lifespan. For example, depletion of mir-150 increased the survival rate from 7.7% to 28.1% in 
30-month-old male mice. The suppression of renal insulin/IGF/AKT activity and upregulation 
of hepatic ACC activity might partially be responsible for the improved lifespan of mir-150 
deficiency275. Conversely, over-expression of lin-4 increased the lifespan of C.elegans, with 
the insulin-like signaling pathway proposed to be the underlying targets276. Similarly, in 
drosophila, loss of mir-14 resulted in a reduced lifespan and semi-lethality, possibly owing to 
its effects of increasing the levels of TG and diacylglycerol as well as to the increase of its 
possible targets of apoptotic effectors277. 
These results suggest that miRNAs might have strong impacts on various age-related 
disorders. 
 
1.2. MiRNAs in age-related diseases 
1.2.1.  Age-associated cardiovascular diseases 
Advancing age is an unmodifiable risk factor for the development of hypertension 
and cardiovascular diseases. MiRNAs associated with cardiovascular diseases during aging 
are briefly summed in Table 3. 
Mice lacking mineralocorticoid receptors (MR) in smooth muscle cells (SMC-MR-KO) 
are protected from rising blood pressure during aging. In this context, mir-155 was identified 
as the most down-regulated miRNA with vascular aging in MR-intact but not in SMC-MR-KO 
mice. The age-associated decrease in mir-155 in mesenteric vessels was associated with 
increased mRNA abundance of MR and of predicted mir-155 targets such as CAV1.2 (L-type 
calcium channel subunit) and angiotensin type-1 receptor278.  In HEK293 cells, MR repressed 
mir-155 promoter activity. Restoration of miR-155 specifically in SMCs of aged MR-intact 
mice decreased CAV1.2 and AGTR1 and attenuated LTCC-mediated and angiotensin II-
induced vasoconstriction and oxidative stress278. Moreover, mir-155 levels in serum 
predicted the blood pressure treatment response in a clinical trial of MR blockade in elderly 
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humans278. Thus, the regulation of mir-155 by SMC-MR contributes to vasoconstriction 
during aging278. 
One one hand, endothelial progenitor cells (EPCs) contribute to the regeneration of 
endothelium. Aging-associated senescence results in reduced number and function of EPCs, 
possibly contributing to increased cardiac risk and impaired cardiac repair effectiveness. 
Increased levels of mir-10a* and mir-21 were demonstrated to be responsible for the age-
associated senescence in old EPCs, by suppressing HMGA2 (high mobility group AT-hook 2). 
In contrast, suppression of these two miRNAs in aged EPCs, rejuvenated EPCs and increased 
self-reneval potential and decreased senescence markers by rescuing the level of HMGA2279. 
In the short-lived turquoise killifish Nothobranchiusfurzeri (Nfu), mir-29 family 
robustly increased in the heart with age. Mir-29 knockout in zebrafish with mir-29 sponges 
induced a significant cardiac spherization and hypertrophy, associated with increased 
deposition of collagen and global 5-methy cytosine (5mC) levels. Moreover, in the context of 
hypoxia of human cardiac fibroblasts, mir-29 down modulation accounted for the 
accumulation of collagens and 5mC. These results indicated that mir-29 family upregulation 
might represent an endogenous mechanismaimed at ameliorating the age-dependent 
cardiac damage leading to hypertrophy and fibrosis280. 
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Table 3 : MiRNAs involved in age-associated cardiovascular diseases 
miRNAs Organ Direction Targets Function Reference 
Mir-29 family 
(-29a,-29b, 
-29c) 
Aortas/ 
WTmice 
up ECM components: 
Collagens/ 
elastin 
Aortic aneurysm 
formation 
281 
Mir-217 HUVECs up Sirt1/FoxO1 Pro-senescence 282 
Mir-34a Heart/ wt 
mice/ ku80-/-
mice 
up PNUTS(PPP1R10) Induction of 
cardiomyocyte 
apopotosis, telomere 
attribution and DDR. 
283 
Mir-22 Cardiac 
fibroblast/ 
C57/B16N 
up mimecan Induction of 
senescence and 
chemotaxis 
284 
Mir-17-3p Mouse 
cardiac 
fibroblasts 
down PAWR/CEBP and 
FAK signaling 
Anti-senescence and 
apoptosis 
285 
Mir-125a-5p Endothelial 
cells/ WT 
mice 
up Transcriptional 
enhancer factor-1/ 
eNOS/VEGF 
Angiogenesis defects 286 
Mir-146a Endothelial 
cells/in vitro 
human 
down Possible targets: 
NOX4 
unvalidated 287 
Mir-217 Human 
HUVEC in 
vitro 
up Sirt1 Pro-senescenece 282 
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1.2.2.  Age-associated sarcopenia and osteoporosis 
 Sarcopenia 
Skeletal muscle is degenerative in mass and function by aging, which is termed 
sarcopenia. Study with muscle biopsy from man demonstrated that aging increased the 
expressions of let-7b and let-7e families associated with decreased their potential targets 
such as CDK6, CDC25A and CDC34 which are critical for cellular proliferation288. In addition, 
next-generation sequencing (NGS) technology permits the precise identification of mature 
and novel miRNAs. Sequencing of microRNAs and mRNAs from mouse gastrocnemius 
muscles from 6- and 24-month-old mice revealed sixteen novel deregulated microRNAs such 
as mir-206, mir-434, and mir-136, most of whose mRNAs targets were correspondingly 
modulated289. The decreased myogenic capacity is a major underlying cause of sarcopenia 
with age. However, the mechanisms remainless well understood. Mir-431 was found 
increased in old myoblasts. Ectopic injection of mir-431 greatly improved muscle 
regeneration through targeting SMAD4 levels and therefore transforming growth factor β 
(TGFβ) signaling, indicating that age-associated mir-431 plays a key role in maintaining the 
myogenic capacity of sketetal muscle with age290. 
 Osteoporosis 
Age-related osteoporosis is characterized by reduced bone formation and increased 
marrow fat accumulation within marrow. The reduction in osteoblast activity is partly caused 
by the fact that bone marrow stromal cells (BMSCs) from elderly subjects have reduced 
capacity to differentiate into osteoblasts and increased capacity to differentiate into 
adipocytes.  Mir-188 was found markedly higher in BMSCs from aged compared with young 
mice and humans. Intra-bone marrow injection of antagomiR-188 increased bone formation 
and decreased bone marrow fat accumulation in aged mice through targeting histone 
deacetylase9 (HDAC9) and RPTOR-independent companion of mTOR complex 2 (RICTOR), 
indicating that mir-188 is a potential therapeutic target for age-related bone loss291. By 
contrast, aging specifically increased the mir-183 cluster in EVs inside bone marrow, and 
possibly drove senescence in BMSCs by endocytosis of EVs into BMSCs292. 
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1.2.3. Age-related liver dysfunctions 
Gradual increases in the levels of mir-669c and mir-709 were observed in aged liver in 
mice, with their potential targets involving in detoxification activity and regeneration 
capacity function declined in old liver293. The Ames dwarf mouse is one of the long-lived 
mammalian modelwith a point mutation in the PROP1 gene, which can liveup to 70% longer 
than wild-type counterparts. In the liver of Ames dwarf mouse, mir-27a was markedly up-
regulated compared to wild type counterparts, which was associated with a reciprocal 
down-regulation of its putative targets involved in polyamine biosynthesis (ODC1) and 
spermidine synthase (SRM). These data indicate that mir-27a was a key post-transcriptional 
regulator of intermediate metabolism in liver which might contribute to the long-lived 
phenotype in the Ames dwarf mouse294. 
NGS analysis of miRNAs in the whole blood of mice of different ages helped to reveal 
several age-altered ones, amongst which, six were predicted to be involved in non-fatty liver 
disease: mir-16-5p, mir-17-5p, mir-21a-5p, mir-30c-5p, mir-103-3p and mir-130a-3p. 
Moreover, transfection of the six miRNAs into 18-month-old mice actually reduced the 
accumulation of age-related genes in liver, including mir-11a, p16 and mTOR, providing 
preliminary data that reversing age-associated miRNAs could be applied for treatments of 
age phenotype in the future295. 
1.2.4. Age-related immune defects 
Hematopoietic stem cells (HSC) homeostasis is disrupted under physiological stresses 
such as aging and periodic bacterial encounters, associated with declines in HSC number and 
quality. Chronic inflammation is demonstrated to be the major cause of the age-related 
decline in HSC functions. The absence of mir-146a triggered a chronic inflammatory state 
through pathways involving TRAF6/NF-ƘB/IL-6, which chronically could lead to severe 
pathologies, such as HSC exhaustion, bone marrow failure or myeloproliferative disease. 
These data indicate that the single mir-146a is crucial for guarding the quality and longevity 
of HSC in mice296. 
Macrophages are critical effector cells of the innate immune system. Aging has been 
demonstrated to drive a functional drift in macrophages in mice, including epigenomic 
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alterations, impaired cholesterol metabolism and inability to inhibit pathological 
angiogenesis, which is proposed to contribute to the pathogenesis of various aging disorders, 
such as age-related macular degeneration (AMD).  The group of Rajendra S. Apte has 
revealed that the initiation of mir-150 by aging in macrophages of diverse origins, such as 
spleen, bone marrow and peritoneal localization, induced a reprogramming of the 
macrophage transcriptome, with altered phospholipid and ceramide profiles. Moreover, mir-
150 targeted stearoyl-CoA desaturase-2 (SCD2), dysregulating lipid metabolism and 
promoting pathologic angiogenesis. Finally, the upregulation of mir-150 in human peripheral 
blood mononuclear cells was associated with AMD297. 
 
2. MiRNAs to senescence 
2.1. Cellular senescence 
How our cells are affected by aging? The answer might be that as our body turns 
aged, our cells turn senescent (Figure 11). Cellular senescence was formally describled more 
than 40 years ago as a limited proliferation ability of normal human cells in culture298. The 
irreversibility of the senescence arrest is tightly associated with the senescent cell’s special 
chromatin architecture, the so-called senescence-associated heterochromatin foci (SAHF). It 
constitutes a hallmark of senescent cells that contain several common markers of 
transcriptionally repressed heterochromatin and are hypothesized to silence genes 
important for cell proliferation, in particular those regulated by the E2F/RB1 repressor 
complex299. Despite an irreversible cell cycle, senescent cells actively secrete a spectrum of 
proinflammatory cytokines, chemokines, matrix metalloproteinases and growth factors, 
which is termed the senescence-associated secretory phenotype (SASP)300. SASP might be 
one of the manners that senescence employs to promote aging. 
Nowadays, it has been demonstrated that senescent cells accumulate in various 
tissues and organs overtime demonstrated by accumulations of senescence markers such as 
senescence-associated β-galactosidase (SA-β-gal), p53 and cyclin-dependent kinase 
inhibitors p21 and p16. Senescence contributes to aging process. For example, Darren J.B. et 
al has shown that genetic or pharmacological removal of p16Ink4a-positve cells (senescent cells) 
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would induce extended lifespan associated with reduced pathological alterations in various 
organs such as adipose tissue, heart and kidney301. 
It has been demonstrated that various stimuli could induce cellular senescence. On 
the one hand, the telomeric DNA loss during each S phase would result in telomeres erosion, 
which then generates a persistent DNA damage reponse (DDR). DDR then could further 
reinforce the senescence-related growth arrest302. On the other hand, senescence could also 
occur without DDR development under various culture stressors such as serum deprivation 
or oxidative stress, etc303. 
 
Figure 11: Hallmarks of senescent cells.  
Hallmarks of senescent cells include an essentially irreversible growth arrest; expression of SA-Bgal and p16; 
robust secretion of SASP); nuclear foci contanining DDR proteins (DNA-SCARS/TIF) or heterochromatin (SAHF). 
Adapted from
304
. 
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Interestingly, miRNAs have emerged as key regulators in the cellular senescence 
associated gene programs. Disruption of global miRNAs biogenesis by silencing of DGCR8, 
Dicer or Drosha could lead to a senescence-like state in human and mouse primary 
fibroblasts demonstrated by flatted morphology, increased SA-β-gal activity or formation of 
SAHF305,306. So, how miRNAs could affect senescence? In the following part, we are going to 
focus on the effects of miRNAs on the two major pathways involved in senescence. 
2.2. miRNAs in p53/RB tumor-supressor pathways 
Proliferative arrest, one of hallmarks of senescent cells, is induced by both 
endogenous and external influences that ultimately converge on either or both of the 
p16INK4a/ RB and p14ARF/ p53 pathways. The binding of p16 to the cyclin-dependent kinase 4-
6/ cyclin D complex inhibits the phosphorylation of pRb family proteins and causes a G1 cell 
cycle arrest (Figure 12). 
 
 
 miRNAs upstream of p53/ RB pathways 
In senescence, let-7/agronaute2 (AGO2) signaling induced implementation of silent-
state chromatin modification at target promoters. Inhibition of the let-7/AGO2 effector 
Figure 12 : The p53 and RB tumor-
suppresor pathways.  
In the p53 pathway, signals including 
the ARF (also known as p14 in human 
and p19 in mice), production of the 
CDKN2A locus, increase p53 levels by 
sequestering MDM2, which facilitates 
the degradation and inactivation of 
p53. 
In the RB pathway, stress signals indude 
INK4A, the product of the CDKN2A 
locus. INK4A inhibits CDKs that 
phosphorylate, and therefore 
inactivate, RB during the G1 phase of 
the cell cycle. Reviewed in 
1
. 
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complex perturbed the timely execution of senescence307, suggesting that some miRNAs 
could potentially affect senescence via modifying the promoters of p16/p53 and thereby 
their expressions. Similarly, in human mammary epithelial cells, senescence-associated 
miRNAs (SA-miRs) such as mir-26b, mir-181a function in concert to repress expressions of 
polycomb group proteins, embryonic ectoderm development or enhancer of zeste 
homologue 2, thereby activating expression of p16 and senescence308. Likewise, amongst the 
human cancer-associated mir-17-92 cluster, mir-17/mir-20a seed family are necessary and 
sufficient for conferring resistance to oncogene-induced senescence, by directly targeting 
p21WAF1309. 
Senescence in the type II alveolar epithelial cells (AECs) contributes to the 
development of idiopathic pulmonary fibrosis (IPE). The upregulation of SA-miRs including 
mir-34 family and mir-20a, mir-29c and let-7f might participate in the induction of 
senescence in AECs, with its ectopic overexpression inducing senescence markers: p16, p53 
and SA-β-gal310. In addition, induction of mir-29 and mir-30 is necessary for the RB pathway 
driven-senescence through targeting and inhibition of the 3’UTR of B-Myb311, a transcription 
factor that negatively regulates senescence312. Moreover, mir-29 overexpression induced by 
Wnt-3a in muscle progenitor cells (MPC) during aging, induces senescence via targeting the 
3’ UTR of p85α, IGF and B-Myb, suppressing the translation of these mediators of myoblast 
proliferation. Finally, electroporation of mir-29 into muscles of young mice recapitulates 
aging-induced responses313. 
Amongst these SA-miRs in human keratinocytes (NHKs), ectopic overexpression of 
mir-137 or mir-668 induced senescence in rapidly proliferating NHKs, demonstrated with 
increased SA-β gal activity and expression of p16 and p53314. 
P16 could improve and stabilize the levels of p53 through negatively regulated p53 
suppressor MDM2 oncoprotein, which was mainly mediated by mir-141 and mir-146-5p 
dependent negative regulation of MDM2315. 
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 miRNAs downstream of p53/RB pathways 
On the other hand, some miRNAs are identified as down stream effectors of 
senescence marker genes. Recent evidence indicated that p16 is a modulator of gene 
expression. It has been demonstrated that p16 could contribute to senescence through 
modulating miRNAs expression. For instance, through the formation of the p16-CDK4-Sp1 
heterocomplex which binds to the Sp1 consensus-binding motifs present in the promoters of 
mir-141 and mir-146b-5p, p16 enables the transcription of mir-141 and mir-146b-5p, which 
mediate p16’s response to ultraviolet (UV) induced DNA damage316. 
2.3. miRNAs in DNA damage pathways 
The most significant phenotype associated with mammalian cellular aging is telomere 
shortening which induces disruption of chromosome integrity by DNA damage and 
apoptosis317. Telomerase lengthens telomeres in DNA strands by adding DNA sequence 
repeats (TTAGGG in all vertebrates) to the 3’ end of DNA strands in the telomere regions, 
which are found at the ends of eukaryotic chromosomes, thereby preventing senescent cells 
from postmitotic condition and apoptosis318. However, aging is linked with reduced 
telomerase activity which reduces the regenerative capacity of proliferative organs and 
increases incidences of diseases onset and development319. Interestingly, mir-195 was 
overexpressed in old mesenchymal stem cells (OMSCs) in mice, which targeted telomerase 
reverse transcriptase. Abrogation of mir-195 in OMSCs resulted in increased length of 
telomere in the nucleus, markedly improving their proliferative abilities. Moreover, 
transplantation of mir-195-knockout OMSCs reduced infarction size and improved heart 
function in mice320. 
MiRNAs are also involved in the regulation of cellular reactive oxygen species (ROS) 
level which is major contributor to DDR. Surprisingly, in human HEK293 cells, induction of 
DDR by exposure to H2O2 resulted in phosphorylation of dicer (the miRNA producing enzyme) 
and subsequent nuclear recruitment of dicer to promote DNA repairment mediated by 
repair factors MDC1 and 53BP1321, indicating that  some miRNAs might be involved in this 
process. 
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Specifically, mir-31, a novel target of histone deacetylase inhibitor (HDACi) in breast 
cancer cells, induces cellular senescence via repression of the polycomb group (PcG) protein 
BMI1. Mir-31 overexpression leads to γH2AX foci formation largely due to induction of 
mitochondrial ROS322. Although in kidney the molecular basis for aging is not well 
understood, it was reported that mir-335 and mir-34a were increased in aged rat kindney, 
corresponding with down regulation of their targets superoxide dismutase 2 (SOD2) and 
thioredoxin reductase 2 (Txnrd2), respectively, which are critical antioxidants located in 
mitochondria. In vitro experiments demonstrated that overexpression of these two miRNAs 
leaded to senescence of young mesangial cells via suppression of SOD2 and Txnrd2 
associated with a concomitant increase in ROS. Conversely, inhibition of these two actors in 
aged mesangial cells inhibited senescence via upregulation of SOD2 and Txnrd2 with 
decreased ROS323. 
 
3. MiRNAs in conserved aging 
Various conserved pathways have been unvealed to be essential for aging process. 
For example, age-related oxidative stress is associated with functional decline of cellular 
repairing mechanisms and contributes to the onset of age-asscoiated pathologies, such as 
cardiovascular diseases. The accumulation of ROS could induce expression of TGF-β, 
activating fibroblasts and collagen deposition, which is the initial step of fibrotic 
diseases324,325. In drosophila, Jun-N-terminal Kinase (JNK) pathway confers tolerance to 
oxidative stress and extends life span, which is mediated by the activation and nuclear 
translocation of FOXO, repressing insulin/IGF-signaling pathway326. In drosophila 
melanogasterm, a heteroallelic, hypomorphic genotype of mutant InR, which is homologous 
to mammalian insulin receptor, could yield up to 85% of extension in longevity in females 
and reduced late age-specific mortality in males327. Ribosomal S6 protein kinase 1 (S6K1) is a 
downstream component of the nutrient-responsive mTOR (mammalian target of rapamycin) 
signaling pathway. Deletion of S6K1 leads to lifespan extension and resistance to age-related 
pathologies such as bone, immune, motor dysfunction and loss of insulin sensitivity328. 
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Evidence indicates that age-related miRNAs are intimately associated with age- 
conserved pathways. For example, bioinformatic analysis through gene ontology (GO) and 
Kyoto encyclopedia of genes and genomes (KEGG) suggest the target genes of deregulated 
miRNAs in aged left ventricular (mir-132, mir-222 and mir-182, etc.) are enriched in 
conserved pathways such as mTOR signaling pathway, FOXO signaling pathway and 
adipocytokine signaling pathway329. Therefore these data suggest that miRNAs might impact 
aging process through affecting conserved aging pathways. 
Currently, caloric restriction (CR) is one of the most robust interventions shown to 
delay aging in diverse species.  Pharmaceutically, the polyphenol reveratrol, an activator of 
sirtuins, has been proposed to promote healthy aging and extend lifespan330. Therefore, in 
the following part, we mainly focus on relations between miRNAs with CR as well as sirtuin 
families to undertand the participation of miRNAs in aging. 
3.1. miRNAs affecting caloric restriction process 
Similar to caloric restriction (CR), intermittent fasting extends lifespan of C. elegans 
and also mammals. Interestingly, the expressions of miRNAs machinery genes, such as 
Drosha, Argonaute and GW 182, are increased by this process. Conversely, the beneficial 
effects of fasting would be totally abrogated with Drosha depletion. These data, therefore, 
imply that miRNAs abundance might be upregulated by CR and be positively associated with 
CR-linked longevity. Microarray data further propose DAF-16, an effector of insulin/IGF-
signaling, might be a downstream target of cellular miRNAs abandance’s pro-longevity 
action331. So, what are the miRNAs involved in CR in diverse organisms? 
Firstly in C.elegans, it has been reported that mir-80 is a major regulator of the CR 
process. Mir-80 depletion conferred healthy aging, including maintained cardiac-like and 
skeletal muscle-like function at advanced age, and reduced accumulation of lipofuscin and 
extended lifespan, coincident with induction of physiological features of CR. Mechanistically, 
the expression of mir-80 is positively associated with the food availability. The 
acetyltransferase transcription co-factor CBP-1, interacting transcription factors daf-
16/FOXO and heat shock factor-1 are essential for mir-80 deficiency’s benefits332 (Figure 10). 
Other miRNAs, such as mir-71 and mir-228 are also critical for the response to dietary 
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restriction in C. elegans, which are essentially and positively regulated by pHA-4 (a FOXA 
homolog) and SKN-1 (a NRF-related transcription factor)333 (Figure 13). 
Secondly, in rodents, it was also reported that the inhibition of miRNAs biogenesis by 
dicer depletion in adipocytes mitigated the metabolic benefit of CR, which was due to 
impaired insulin signaling caused by mTORc1 hyperactivation. In addition, there was a 
shifted metabolism from oxidative metabolism to amino-acid utilization accounted by 
altered mitochondrial morphology334. In liver, expression of mir-125a-5p was down 
regulated while its targets STAT3, CASP2 and STARD13, were increased with age. 30% of CR 
would significantly reverse the expression of mir-125a-5p and its three targets, suggesting 
that mir-125a-5p contributes to the CR-mediated delay of aging liver335 (Figure 13). In brain, 
the decline in cognitive robustness with aging could be delayed by CR via upregulation of 
anti-apoptotic regulatory proteins that may prevent neuronal death. Interestingly, CR 
decreased the age-linked expressions of mir-30e and mir-34a, as well as reversed the 
decreased ratio of BCL2 to BAX in the brain. In vitro 3’ UTR reporter assay demonstrated that 
BCl2 is a direct target of mir-30e and mir-34a. Therefore, these data indicates that down 
regulation of mir-34a and mir-30e could mediate neuroprotective roles of CR in the brain 
through targeting apoptosis336 (Figure 10). Although levels of certain miRNAs per se might not 
be modulated substantially by aging, their alterations in response to CR could mediate its 
pro-survival effects. For instance, down-regulation of mir-34a, -34e,-181a-1* delayed brain 
aging via upregulation of BCL-2 pro-survival pathway under CR336. 
Thirdly, in primates, regression analysis revealed correlations between body weight, 
adiposity, and insulin sensitivity for about 10 of the CR-regulated known plasma miRNAs in 
rhesus monkeys. Sequence alignment and target identification for these 10 miRNAs 
identified a role in signaling downstream of the insulin receptor. Among them, the highly 
abundant mir-125a-5p in plasma correlated positively with adiposity and negatively with 
insulin sensitivity and was negatively regulated by CR337 (Figure 13). 
In sum, the knowledge of the category of “aging-related miRNAs” as well as the 
precise mechanisms underlying the role of miRNAs in aging is still at the preliminary stages. 
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Figure 13: Simple illustrations of microRNAs’ participations in calorie restriction process in different species. 
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3.2. miRNAs affecting sirtuin families 
Mammalian sirtuins comprise a conserved protein family of seven members of NAD+-
dependent deacetylases or, in case of SIRT4, ADP-ribosyltransferases. SIRT3, SIRT4 and SIRT5 
are exclusively found in the mitochondrium. Increased expression of Sirtuins lowers the risk 
of age-related diseases.  Various miRNAs have been demonstrated to affect aging via sirtuin 
family proteins. 
 miRNAs with SIRT1 
In peripheral blood mononuclear cells (PBMC), age-related decrease of SIRT1 was 
found negatively correlated with the expression of mir-34a and mir-9, with both of the two 
functionally interacted with the 3’ UTR of SIRT1, indicating that mir-9/34a might impact the 
longevity through SIRT1338. The relation between mir-34a and SIRT1 was further confirmed 
in the case of kallistain, an endogenous protein protecting against vascular injury by 
inhibiting oxidative stress and inflammation in hypertensive rats and enhancing the mobility 
and function of endothelial progenitor cells (EPCs). In vitro data supported that kallistain 
could block the TNFα-induced senescence in EPCs via inhibiting the synthesis of mir-34a and 
mir-21, which negatively targeting SIRT1 and eNOS. Furthermore, mutation of mir-34 
abrogated the life-extending effects of kallistain in wild-type C.elegans under oxidative or 
heat stress in a SIRT1-dependent manner339. Moreover, age-related hearing loss, also known 
as presbycusis, is thought to be the irreversible loss of cochlear hair cells in the inner ear.  
Upregulation of mir-34a was again demonstrated to contribute to the apopotosis of HEI-OCI 
cell and hair cell loss in mice through targeting SIRT1 which resulted in an increase in p53 
acetylation, suggesting the mir-34a/SIRT1/p53 signaling might serve as a potential target for 
age-related hearing loss treatment340 (Figure 14A). 
 miRNAs with SIRT4 
Conversely, Sirt4 level is upregulated in senescence, inversely correlated with mir-
15b in photoaged human skin. Inhibition of mir-15b promotes mitochondrial ROS generation 
and reduces mitochondrial membrane potential as well as impacts the expression of 
components of SASP in a SIRT4-dependent mannar. These data indicate the mir-15b/SIRT4 
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axis mediated the stress-induced senescence associated with mitochondrial dysfunction and 
SASP regulation341 (Figure 14B). 
 miRNAs with SIRT6. 
SIRT6 specifically deacetylases lysine 9 on histone H3 (H3K9Ac) or lysine 56 on 
histone H3 (H3K56Ac). In addition, SIRT6 is able to form a macromolecular complex with the 
DNA double-strand break repair factor DNA-dependent protein kinase (DNA-PK) to promote 
DNA double-strand break repair342. Physically, it interacts with poly (adenosine diphosphate-
ribose) polymerase 1 (PARP1) and mono-ADP-ribosylates PARP1 on lysine residue 521, 
thereby stimulating PARP1 poly-ADP-ribosylase activity and enhancing double-strand break 
repair under oxidative stress343. SIRT6 knockout mouse cells exhibit genomic instability and 
hypersensitivity to DNA damage. Moreover, SIRT6-/- mice have been shown to develop a 
severe degenerative phenotype similar to that of premature aging. On the contrary, 
overexpression of SIRT6 in mice could increase the life span of male mice344. SIRT6 level was 
reduced in human dermal fibroblasts derived from older subjects compared to that from 
young subjects, coincided with an augmentation in the level of mir-766. In vitro experiments 
show that mir-766 post-transcriptionally regulated the expression of SIRT6, which could 
negatively regulate mir-766 transcription via a feedback regulatory loop through modulating 
acetylation levels at its promoter (Figure 14C). These data indicate that miRNAs have 
implications in the post-transcriptional regulation of SIRT6, which is vital for longevity345. 
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Figure 14: Examples of effects of microRNAs in sirtuins during aging or senescence. 
(A) Aging-associated increase in mir-34a promotes p53 expression and apopotosis through inhibition of SIRT1. 
(B) Loss of mir-15b accounts for upregulation of mitochondrial ROS production by increased SIRT4 in cellular 
senescence. (C)  Loop regulations of mir-766 and SIRT6 during aging. 
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PART IV: A novel method of culturing isolated adipocytes 
1. Current in vitro models of adipocytes 
The main functional unit inside adipose tissue are adipocytes, characterized by a 
unilocular lipid droplet and a peripherally located nucleus. Knowledge of adipocytes is 
fundamental to enhance our understanding of adipose tissue physiology/pathology. As early 
as in 1964, Rodbell M. firstly isolated mature adipocytes from adipose tissue with 
collagenase digestion346. However, turning to literature, it is surprising that currently there is 
no effective system to maintain mature adipocytes for in vitro culture, which greatly limits 
our understanding of the fat cells. Then, why adipocytes could not been cultured in vitro 
routinely? Because of engaging in lipid storage, adipocytes are highly buoyant and will float 
on top of cell culture media, which will then result in malnutrition and osmotic stress. So, 
currently what are the models for us to study adipocytes in vitro? 
1.1. Two-dimensional (2D) adipogenesis of preadipocytes 
Currently, in vitro culture of adipocytes is perfomed on generic 2D polystyrene. 
Cellular model systems including pluripotent fibroblasts such as 10T1/2, BALB/c-3T3 and 
RCJ3.1, as well as fibroblast-like preadipocytes that are committed to differentiate into 
adipocytes such as 3T3-L1, 3T3-F422A, 1246, and 30A5, are widely used to investigate 
adipogenesis and functions of adipocytes. Among them, 3T3-F442A and 3T3-L1 are the two 
most extensively characterized and used preadipocyte cell lines. Both of these cell lines are 
derived from disaggregated 17- to 19-day old Swiss 3T3 mouse embryos347. However, dislike 
mature adipocytes which contain a single lipid droplet, in vitro differentiated adipocytes are 
characterized by multiple lipid droplets and accompanied undifferentiated preadipcoytes 
(Figure 13). Moreover, it has been reported that they could only produce 1-2 % of leptin of 
that of mature adipocytes348. Indeed, these cell lines are immortalized aneuploid cells whose 
genetic regulation may be distorted349. 
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Figure 15 : 3T3-F442A adipocytes differentiated from 3T3-F442A fibroblasts. 
 
Beside the use of preadipocytes from immortalized cell lines, primary culture of the 
isolated stromal vascular fractions (SVFs) from adipose tissue is also widely used to study 
adipocytes in vitro (Figure 14).  Adipogenesis of SVFs is induced by hormone cocktails 
stimulation including insulin, 3-isobutyl-1-methylxantine (IBMX), dexamethasone, etc124. 
Similarly, SVFs would differentiate into multiple lipid droplets. 
 
 
Figure 16: Isolation of SVF from adipose tissue with collagenase digestion and centrigugation for in vitro 
adipogenesis. 
 
 
Finally, during differentiation and lipid accumulation, adipocyte buoyancy increases 
due to decreasing cell density and causes differentiated adipocytes to detach from planar 
culture surface and lyse. 
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1.2. Three-dimensional (3D) adipogenesis of preadipocytes 
In parallel of the classical adipogenesis on 2D polystyrene, efforts have also been 
made to improve the physiological relevance of in vitro studies, and cell culture technologies 
are in development to mimic the in vivo accommodation of 3D adipocyte expansion. Several 
platforms have been developed to surmount the limitations of 2D culture on adipocyte 
morphology. For example, 3D structure of scaffolds for adipognesis have been made from 
various materials such as particulate-leached polyglycolic acid350, silk fibroin351, meshed 
microfibers352, esterified hyaluronic acid sponges353, electrospunpolycaprolactone354, poly L-
lactic acid355, or freeze-dried mixtures of nanocellulose and alginate356. It has been reported 
that the 3D culture of mature adipocytes from the preadipocytes with scaffolds, allow the 
differentiated adipocytes acquired spheroid shapes and form muticellular aggregates. 
Moreover, compared to 2D culture, the sizes as well as the viablility of mature adipocytes 
from 3D culture significantly are increased357 (Figure 15). Unfortunately, porous materials 
often exceed the acceptable scaffold rigidity and preadipocytes embedded directly in 
hydrogel may remain functionally impaired. 
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Figure 17: 3D adipogenesis of 3T3-L1 cells inelectrospun polycaprolactone scaffolds.  
(A) Once hydrated the scaffold can be easily handled with fine scissors. (B) SEM observation of the dehydrated 
scaffold. (C) Observations of growing cells and fluorescence images of the live/dead assay at day 28 (scale bar: 
100μm). Data is from 
357
. 
 
In another way, to mimic extracellular environment of adipocytes in vivo, which is 
composed of preadipocytes, adipocytes, interstitial cells and a microvascular system 
entwined with collagen-rich ECM, the conjugation of a genetically engineered elastin-like 
polypeptide (ELP) and a synthetic polymer, polyethyleneimine (PEI) (ELP-PEI) was coated on 
classical polystyrene plates, allowing the formation of spheroids of 3T3-L1 adipocyte 
aggregates with 72 hour after seeding358 (Figure 16). These spheroids are cellular aggregates 
allowing cell interactions through junctional complexes. 
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Figure 18: Formation of spheroids of 3T3-L1 adipocyte aggregates on surface tethered with ELP-PEI.  
3T3-L1 cells were differentiated on surface tethered without (left) or with (right) ELP-PEI. Adopted from
358
. 
 
2. First attempt to culture isolated adipocytes 
Then, are there attempts having been made to culture isolated adipocytes directly? 
The answer is sure. 
In 1986, Hajime Suihara et al firstly reported the so-called “ceiling culture” of fat cells. 
The authors took advantage of the buoyancy of these cells, allowing them to float and attach 
on the upper surface of a flask, which was previously fully-filled with medium and was air-
free. After firm attachment, the flask was then placed upside down to allow regular 
observation. However, the author observed dedifferentiation of the cultured adipocyte on 
the 4th day, which would continue so that the previous unilocular cells were finally replaced 
by multilocular fat cells or fibroblast-like fat cells, which in turn proliferated extensively, 
indicating that cultured adipocyte gradually lose their identity359 (Figure 17). 
Then, in 2000, HH Zhang et al tried to modify the “ceiling culture” by culturing 
adipocytes underneath a floating glass surface in wells of 6-well plate, so that their methods 
could be employed for fluorescence microscopy. However, there are still uncertainties since 
adipocytes would escape from the periphery of the glass slide, and it is quite unpractical 
because culture medium could not be changed within 10 to 14 days in order to ensure their 
attachment onto the covering glass. Similarily, the unilocular identity of fat cells could not be 
maintained and adipocytes were fragmented, which they mistakenly taken as budding of a 
daughter cells360. 
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Figure 19: Ceiling culture of isolated adipocytes.  
(a) Experimental scheme ofceiling culture. (b-d) SEM observations of adipocytes gradually change the 
unilocular LD into multiple LD, scale bar, 10μM. Adopoted from
359
.  
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Besides 2D culture of isolated adipocytes, Hajime Sugihara et al, also tried to culture 
fat cells in 3D with collagen gel matrix, in which they embedded fat cells in 2mm in depth 
collagen bed to sequester the fat cell from floating. Unfortunately, the dedifferentiation 
process would still take place within one week of culture361. 
Due to the dedifferentiation of these cultured adipocytes, the method of “ceiling 
culture” or 3D culture with collagen could therefore not be prevailed. Then why attenched 
adipocytes would undergo dramatic dedifferentiation? Unfortunately, there’s no clear 
answer to this phenomenon. However, it might be related to the factor that white 
adipocytes nowadays have been demonstrated with plenty of plasticity. Despite their 
committed status, mature adipocytes maintain a siginificant expression of genes involved in 
stem cell pathways. Very interestingly, it has been reported that cytoplasmic gap can form in 
adipocytes at the early stage of “ceiling culture” and large LDs would be released directly 
outside adipocytes, which is termed liposecretion362. 
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EXPERIMENTAL RESULTS 
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Project I: 
Role and regulation of microRNAs in adipose tissue during aging 
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Questions:  
Although recent studies suggest that adipocyte dicer is decreased in aged mice and is 
involved in the determination of longevity in C. elegans and mice, the underlying 
mechanisms remain largely unknown363. Moreover, previous studies concerning the effects 
of adipocyte dicer are mostly obtained with aP2-dicer or adiponectin-dicer mice neglecting 
the influence of developmental defects in these models. In addition, more and more studies 
suggest that beside the classical drosha/dicer pathway, there are non-canonical pathways 
producing miRNAs in vivo, suggesting that the protein dicer per se might have a role in the 
control of longevity. In this way, the protein dicer per se in adipocytes might be proposed as 
a pharmaceutical target in the promotion of healthy aging. Based on these backgrounds, two 
aspects of age-associated dicer loss could be considered: 
 
1) What are the consequences of adipocyte dicer deficiency in aging process? 
 
2) Are there age-related microRNAs in adipocytes that might positively or negatively 
participate in age-related process? 
 
Therefore, during my PhD, we develop different strategies to:  
I. confirm that adipocyte dicer (miRNAs) affects the physiology of adipose tissue or 
pheripheral organs. To that aim, we used the inducible dicer knockout mice model in 
which the floxed dicer allele is specifically turn down with the adiponectin-Cre which 
is under the control of ERT2 receptors and could be activated by tamoxifen 
treatment. 
II. better understand  the mechanism concerning dicer alterations in adipocytes. 
III. screen by microarray the potentially interesting age-related adipocyte miRNA and 
validate by qPCR. 
IV. assess the role of a selected age-related adipocyte miRNA in aging of adipose tissue. 
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Result 1: Role and regulation of microRNAs in adipose tissue during aging 
A. Validation of the  inducible adipocyte dicer knockdown mice model 
The AdipoCreERT2-DicerLox/lox mice were obtained by crossing Adiponectin-CreERT2 
mice and Dicerlox/lox mice. After breeding and backcrossing the strain over seven generations, 
we obtained a colony of AdipoCreERT2-DicerLox/lox mice. After genotyping, around six-month-
old male mice bearing homozyotes of dicer flox alleles plus adiponectin-CreERT2 
heterozygotes were selected and paired (Figure 1A).  As this construction contains an ERT2 
cassette rendering it inducible, mice were subjected to three times of tamoxifen (200mg/kg) 
gavage within approximately two months as already described364 (Figure 1B). Protein levels 
of dicer were demonstrated to be down regulated at the end of the protocol in DicerLox/lox / 
adiponectin-CreERT2+ (thereafter termed iADicer KO) mice than that in DicerLox/lox/ 
adiponectin-CreERT2-  (thereafter termed control) mice (Figure 1C and 1D). RT-qPCR results 
further demonstrated that dicer levels were significantly reduced by around 30% to 40% 
with tamoxifen treatment in adipocytes isolated from perigonadal and subcutenous adipose 
tissue from the group of iADicer KO mice compared to that in control mice (Figure 1E and 1F, 
respectively). Correspondingly, mir-143, one of the adipocytes enriched microRNAs, was 
significantly decreased by around 40 to 50% in perigonadal adipocytes in iADicer KO mice 
compared to that from control mice (Figure 1G). 
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Figure 1: Inducible reduction of dicer in adipocytes by tamoxifen in dicer
Lox/Lox
/ adiponectin-CreER
T2+
 mice. 
 (A) Genotyping results of dicer
Lox/Lox
/ adiponectin-CreER
T2
 transgenic mice. (B) Experimental protocol:  around 
six-month-old male mice (dicer
Lox/Lox
/ adiponectin-CreER
T2-
 and dicer
Lox/Lox
/ adiponectin-CreER
T2+
) were 
subjected to three times of orally given tamoxifen (200mg/kg) administration within 2 months. Each time of 
administration included 5 consecutive days of tamonxifen gavage. (C and D) Protein levels of dicer were 
successfully down regulated in perigonadal and subuctaneous adipose tissues at the end of the protocol. RNA 
levels of dicer were significantly reduced in isolated adipocytes from perigonadal (E) and sucutaneous (F) 
depots. (G) Mir-143 level was decreased in isolated adipocytes from perigonadal fat. Data represent the 
mean±SEM, *P<0.05, **P<0.01. N=4-8. 
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B. Adipocyte dicer deficiency triggered a waste of perigonadal fat 
To investigate the role of adipocyte dicer (miRNAs) in the physiology of adipose tissue 
per se, we characterized the body weight of the mice, the body fat proportion by EchoMRI as 
well as the sizes of adipocytes in subcutaneous and perigonadal adipose tissue by H&E 
staining at the end of the protocol. 
Firstly, adipocyte dicer deficiency did not significantly alter the body weight of mice 
in this protocol (Figure 2A). However, adipocyte dicer deficiency significantly reduced the 
body fat proportion (Figure 2B). In agreement, the ratio of perigonadal fat to body weight 
was significantly reduced by over 50% in comparison to control group (Figure 2C), whereas 
the ratio of subcutaneous fat to body weight was unaltered (Figure 2D). Then, the result of 
H&E staining revealed that the average cell size of perigonadal adipocytes was reduced by 
near 50% by dicer deficiency, while deficiency of dicer had a trend to reduce the sizes of 
subcutaneous adipocytes (Figure 2E, 2F and 2G). Therefore, these data indicated that 
adipocyte dicer deficiency resulted in a loss of perigonadal fat mass accounted partly by 
reduced volumes of adipocytes. 
Molecular studies were then performed to to confirm these data as well as to 
investigate the underlying mechanisms. RT-qPCR results demonstrated that dicer deficiency 
led to dramatic reductions in Leptin, Fsp27, two genes known to be positively associated 
with adipocyte sizes (Figure 2H). Moreover, metabolic functional genes such as Pparγ1/2, 
Glut4, Hsl, Atgl and Pepck were also markedly decreased following dicer deficiency, 
indicating a possibility of attenuated adipocyte functions such as glucose transport and 
lipolysis (Figure 2H and 2I). The lipid droplet (LD) is stabilized by a surrounding monolayer of 
phospholipids with adherent proteins, in particular perilipin 1 (PLIN1), which could act dually 
to both suppress basal lipolysis and augment catecholamine stimulated lipolysis362,363. The 
result of immunofluorescent staining exhibited that PLIN1 was markedly reduced with dicer 
loss in perigonadal adipocytes (Figure 2G).  
Therefore, these results indicated that dicer abundance is indispensible for the 
maintenance of adipocytes identities in perigonadal adipose tissue. Therefore, in the 
following part, we mainly focused on the study of this adipose tissue. 
 
87 
 
 
 
Figure 2: Reduction in the average sizes of perigonadal adipocytes due to dicer deficiency. 
(A) Body weight between the two different genotypes at the end of the sacrifice. (B) Body fat proportion of the 
mice measured by EchoMRI at the end of the protocol. (C and D) Perigonadal and subcutaneous fat to body 
weight ratios. (E) H&E staining of the perigonadal and subcutaneous adipose tissue. (F and G) Average cell sizes 
of perigonadal and subcutaneous adipocytes. (G) Dramatic downregulations of white adipocyte gene markers 
associated with dicer decline in adipocytes by qPCR. (H) Reduced protein level of HSL in perigonadal fat 
revealed by immunoblotting. (I) Reduced protein level of PLIN1 in perigonadal adipocytes exhibited by IF 
staining. Data represent the mean ± SEM, *P<0.05, **P<0.01. N=4-8. 
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C. Possible mechanisms underlying the effects of adipocyte dicer deficiency 
As adipocyte size is mainly determined by its lipid contents, so we went on to 
investigate whether adipocyte lipid metabolism was affected by dicer deficiceny, and we 
then turned our attention to mitochondria. 
Surprisingly, PGC1α, one of the transcriptional factors important in the transcription 
of genes involved in mitochondrial biogenesis and functions, was significantly upregulated in 
perigonadal adipocytes due to dicer deficiency at both the level of mRNA and protein (Figure 
3A and 3B). In addition, OXPHOS complex II/IV were significantly upregulated in perigonadal 
adipocytes due to dicer deficiency, and there was a strong trend for complex III to be 
increased (P=0.606) (Figure 3C). Although mitochondria recently have been suggested to be 
able to consume extra nutrients in subcutaneous adipose tissue365, it is also a major source 
of reactive oxidative species (ROS)366. Therefore, to better evaluate the state of 
mitochondria, antioxidant systems were checked. Interestingly, mRNA levels of antioxidants 
such as Catalase and Sodium oxide dismutase (Sod) were significantly reduced in perigonadal 
adipose tissue due to dicer deficiency (Figure 3D). Therefore, adipocyte dicer deficiency 
might induce a combination of mitochondrial activation and reduction in detoxification. 
According to literature, the transcriptional factor FOXO families are able to promote the 
transcription of antioxidant genes, like Catalase and Sod367, but also negatively regulate the 
transcription of genes important for mitochondrial functions368. The phosphorylation of 
FOXO families would lead to their relocation from nucleus to cytoplasma, thereby inhibiting 
their transcriptional activities369. Interestingly, the result of immunoblot showed that the 
phosphorylation of both FOXO1 and FOXO3 was increased in perigonadal adipose tissue due 
to dicer deficiency (Figure 3F), suggesting that adipocyte dicer deficiency might lead to 
inactivation of FOXO1 and FOXO3. Additionally, reduction in autophagy, one of downstream 
effector of FOXOs370, was also possibly inhibited by adipocyte dicer deficiency demonstrated 
with Bnip3 reduction (Figure 3G), further in favor the possibility that adipocyte dicer 
deficiency reduced FOXOs activitions. Therefore, with these preliminary data, we assurmed 
that adipocyte dicer deficiency resulted in a combination of mitochondria activation and 
detoxification reduction possibly mediated by FOXO1 and FOXO3a inactivation. 
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Figure 3: Possible involved mechanisms underlying the effects of adipocyte dicer deficiency. 
(A) RT-qPCR of genes involved in mitochondrial functions in perigonadal adipocytes. (B) Protein level of PGC1α 
in perigonadal adipocytes. (C) Quantification of protein levels of OXPHOS components in perigonadal 
adipocytes. (D) Downregulations of antioxidant genes of Sod and Catalase due to dicer deficiency in 
perigonadal adipocytes. (F) Increased phophorylations of FOXO1 and FOXO3a in perigonadal adipose tissue due 
to reduced adipocyte dicer deficiency. (G) Autophagy gene Bnip3 was negatively affected in perigonadal 
adipose tissue due to dicer deficiency. Data represent the mean ± SEM, *P<0.05, **P<0.01. N=4-8. 
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D. Altered systemic energy homeostasis with adipocyte dicer deficiency 
To better understand whether adipocyte dicer deficiency would lead to systemic 
effects, we characterized the plasma levels of various metabolites and hormones (Table 1). 
Although reaching no significance, there was a trend for plasma lipids such as TG, NEFAs and 
cholesterol to be decreased due to dicer deficiency in adipocytes. Of note, the plasma level 
of glycerol, a byproduct of lipolysis, was significantly increased because of dicer deficiency in 
adipocytes, indicating either increased basal lipolysis or inability of adipocytes to recycle 
glycerol for the synthesis of TG. The results correlated with the reduced Pepck and PLIN1 
expressions in adipose tissue from iADicer KO mice compared to that in control mice (Figure 
2H and 2G). Surprisingly, plasma insulin exhibited a strong trend to increase to around 2.5 
folds (3.82 ± 0.90 vs. 1.53 ± 0.54), indicating iADicer KO mice might have a higher risk of 
developing systemic insulin resistance (glycemia is not affected). The clinical variables for 
liver function: plasma ALT (alanine aminotransferase) and AST (aspartate aminotransferase) 
levels were comparable between the two groups of mice. In sum, adipocyte dicer deficiency 
led to alterations in systemic metabolism. 
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                    Table 1: Plasma parameters (fed) 
 Control iADicer KO 
Glucose (mg/dl) 203.04 ± 11.59 192.1 ± 9.28 
TG (mg/dl) 1.16 ± 0.16 0.90± 0.26 
Glycerol (mM) 0.083 ±0.0089 0.114±0.0076* 
NEFAs (mmol/L) 0.60± 0.086 0.34± 0.084 
Cholesterol (mmol/L) 1.58 ±0.059 1.37±0.20 
ALT (U/L) 22.03 ±0.033 23.25± 1.74 
AST (U/L) 59.33 ±12.84 62.75± 3.48 
Insulin (µg/ml) 1.53 ± 0.54 3.82± 0.90 
                         Data represent the mean ± SEM, *P<0.05. N=4-8. 
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E. Abnormalities of liver associated with adipocyte dicer deficiency 
To be more convincing that adipocyte dicer affected systemic metabolism, we went 
on to characterize liver, which is an important organ influencing systemic metabolism. 
Interestingly, the result of H&E counter staining exhibited that white dots appeared 
in phase contract microscope illustrating lipid overfilling in livers from iADicer KO mice 
treated with tamoxifen, suggesting that adipocyte dicer deficiency possibly result in lipid 
overload in liver (Figure 4A). To confirm this result and better understand the source of 
lipids in liver from iADicer KO mice, RT-qPCR was performed to detect the genes involved in 
lipid metabolism. Fat-specific protein 27 (FSP27), a lipid droplet-associated protein that 
promotes lipid droplet growth and TG storage was induced from iADicer KO mice compared 
to that from from control mice (Figure 3B), supporting ectopic lipid development in liver 
with adipocyte dicer deficiency. Moreover, genes involved in DNL pathways such as PAPRγ1/2, 
FAS, and CD36 also significantly increased in liver from iADicer KO mice compared to that 
from control mice (Figure 3B). In addition, immunoblot results of PAPRγ1/2 and FAS further 
confirmed that DNL pathway was activated in liver consecutively to adipocyte dicer 
deficiency (Figure 3C). These results indicated that adipocyte dicer deficiency resulted in 
ectopic lipids in liver associated with upregulation of DNL pathway. 
Since the accumulation of lipids is proposed to be crucial in the activation of hepatic 
stellate cells (HSCs) and the development of fibrosis in liver371, we went on to investigate 
whether the ectopic lipids in liver resulted from adipocyte dicer deficiency was associated 
with fibrosis in the liver. Then, the result of semi-quantification of sirius red stained area 
suggested that fibrosis was indeed increased in liver from iADicer KO mice compared to 
control mice (Figure 3D). Furthermore, the results of gene markers involved in extracellular 
matrix (ECM) depositions had a trend to be increased by adipocyte dicer deficiency (Figure 
3E). Moreover, genes involved in inflammatory pathways such as MCP1 and TGF β receptor 1 
(TGFβ r1) were significantly increased in mice from the group of iADicer KO mice (Figure 3E). 
Since MCP1 is an important chemokine that triggers infiltrations of immune cells, in 
particular macrophages, it suggested that increased infiltrations of macrophages might lead 
to the activation of TGF β pathway and accumulation of ECM and thereby fibrosis in liver by 
dicer deficiency in adipocytes. 
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Figure 4: Adipocyte dicer deficiency promoted lipid accumulation and fibrosis in liver. 
(A) The result of H&E staining suggested that adipocyte dicer deficiency resulted in lipid accumulation in liver. 
(B) Increased mRNA levels of genes involved in DNL pathway in liver as a result of dicer deficiency in adipocytes. 
(C)  Increased levels of PPARγ and FAS in liver due to adipocyte dicer deficiency by immunobot. (D) Sirius red 
staining of liver exhibited increased fibrosis as a result of adipocyte dicer deficiency. (E) mRNA levels of genes 
involved in fibrosis and inflammation in liver. Data represent the mean ± SEM, *P<0.05, **P<0.01. N=4-8. 
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F. Regulation of dicer level in adipocytes 
According to our previous data that adipocyte dicer deficiency reduced the lipid 
storage capability of adipocytes as well as induced abnormalities in systemic metabolism, 
like ectopic lipid overload and fibrosis in liver. Therefore, adipocyte dicer might have a 
positive role in the prevention of age-related complications, and adipocyte dicer might be 
proposed as a target to delay the onset of age-related complications. So, to know how this 
protein is regulated in adipocytes will be helpful to develop pharmaceutical compounds 
targeting it. Since adipocytes are sensitive to nutrient availability, we then wondered 
whether nutrient availability would affect dicer in adipocytes. 
Interestingly, 24h fasting significantly increased dicer mRNA level in perigonadal 
adipose tissue in wildtype mice (Figure 5A). Then, in vitro, overnight deprivation of glucose 
in the culture media markedly increased dicer protein level in 3T3-F442A adipocytes (Figure 
5B). Additionally, fetal bovine serum (FBS) contents in the culture media negatively 
regulated dicer protein level in 3T3-F442A adipocytes (Figure 5C). Therefore, negative 
energy state can positively regulate dicer level in adipose tissue and adipocytes.  
Since nutrient deprivation is known to activate the lipolysis process in adipocytes by 
β-adrenergic signaling pathway57. Therefore, we went on to see if dicer upregulation under 
nutrient deprivation is downstream of activation of β-adrenergic signaling pathway, by 
stimulation of adipocytes with 10-6 isoproterenol overnight. However, immunoblot result 
indicated that isoproterenol did not exhibit a similar upregulation effect on dicer as 
starvation (Figure 5D). Therefore, activation of β-adrenergic signaling pathway might not 
affect dicer level in adipocytes. 
To continue to explore the underlying mechanisms how nutrient availability regulates 
dicer in adipocytes, we went on to see whether classical cellular nutrient sensor AMP-
activated protein kinase (AMPK) is involved. Under nutrient deprivation, AMPK can be 
activated by the increased ratio of AMP/ATP, ultimately turning up ATP-generating catabolic 
processes372. In line with the data that fasting or glucose/serum deprivation upregulated 
dicer, treatment of 1mM 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR), 
the activator of AMPK, possibly induced dicer expression in 3T3-F442A adipocytes (N=2) 
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(Figure 5E). In contrast, mild inhibition of AMPK with 20µM Compound C (CC) seemed to 
reduce the basal level of dicer while not affecting the effect of serum deprivation on dicer 
level (N=2) (Figure 5F). But strong inhibition of AMPK with 50µM CC exhibited no obvious 
effect on dicer expression in adipocyts (N=2) (Figure 5F). 
In sum, AMPK might positively regulate dicer expression in adipocytes. However, 
there might be other unknown factors participating in the regulation of adipocyte dicer 
expression. 
 
 
 
 
 
 
 
 
 
 
 
 
96 
 
 
Figure 5: Regulation of dicer level in adipose tissue and in in vitro adipocytes. 
(A) 24h fasting significantly increased mRNA level of dicer in perigonadal adipose tissue in wildtype mice (N=5). 
(B) Overnight glucose deprivation significantly increased dicer protein level in 3T3-F442A adipocytes (N=3). (C) 
Fetal bovine serum contents negatively affected dicer protein levels in 3T3-F442A adipocytes (N=3). (D) 
Overnight stimulation of 10
-6
 isoproterenol did not increase dicer protein expression as serum starvation (N=3). 
(E) Overnight treatment of 1mM AICAR might increase dicer protein level in 3T3-F442A adipocytes (N=2). (F) 
Overnight treatment of various concentrations of AMPK inhibitor compound C differentially affected dicer 
protein level in 3T3-F442A adipocytes (N=2).  Data represent the mean ± SEM, *P<0.05.  
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G. Selection of age-related microRNAs in adipocytes 
In an effort to isolate potential aging-associated miRNA targets in adipocytes, 
previous microRNA-based microarray experiments in mouse visceral adipose tissue have 
been performed in the laboratory (by By Karine Tréguer and Jason S. Iacovoni). Wild type 
mice of 3-, 12- and 24-month-old were used. Through selection, eight potential candidates 
had been isolated including mir-1949, mir-672, mir-125b*, mir-805, mir-494, mir-143 and 
mir-133a. Therefore to continue, RT-qPCR was perfomed to further validate the 8 candidates 
from microarray.   
 
1. Validation of miRNAs candidates from microarray 
Surprisingly, among the candidates, only mir-1949 was found significantly 
upregulated in vWAT from 20-month-old mice compared young (6-month-old) control mice 
(Figure 6A and 6B). Therefore, to be sure of the result, another set of experiment was 
performed. Similarly, mir-1949 was found dramatically upregulated in both whole vWAT and 
sWAT collected from 24-month-old mice and compared to 3-month-old mice (Figure 6C and 
6D). Moreover, the same result was obtained in isolated adipocytes from vWATand sWAT, 
(Figure 6C and 6D). Finally, its levels were relatively less modified in SVF isolated from vWAT 
and sWAT (Figure 6C and 6D). Therefore, we concluded that mir-1949 might be proposed as 
an age-related miRNA in adipocytes. 
Since miRNAs are also stable in the circulation and could positively be secreted by 
cells, we went on to investigate whether there was also an increased secretion of mir-1949 
from adipocytes by aging. To do so, vWAT was isolated and cut into small pieces and then 
cultured in vitro. Conditioned medium (CM) was collected at the time points of 0.5h and 2h. 
Mir-1949 levels in CM were detected by qPCR. Interestingly, mir-1949 was elevated in CM 
collected from vWAT of 24-month-old mice compared to 3-month-old mice, indicating that 
aging might possibly increase the secretion of mir-1949 from adipose tissue (Figure 6E). To 
further confirm that aging promotes the upregulation and possibly the secretion of mir-1949 
from adipocytes, we went on to investigate whether adipocyte senescence would also affect 
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this miRNA. To test this hypothesis, we set up an in vitro senescence model of adipocytes by 
long term exposure of 3T3 adipocytes to 0.2M glucose. Upregulations of senescence markers 
such as p16 expression (Figure 6F) and SA-β-galactosidase staining (Figure 6G) demonstrated 
the development of senescence in adipocytes treated by 0.2M glucose. Interestingly, mir-
1949 was both upregulated in senescent adipocytes as well as in CM derived from these 
senescent adipocytes (Figure 6H and 6I). Therefore, senescence of adipocytes also increases 
the production and secretion of mir-1949 in vitro. 
In sum, we firstly reported that mir-1949 could be a potent age-associated miRNA in 
adipocytes. 
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Figure 6: Age-associated increase of mir-1949. 
(A and B) 8 candidates from microarray were further validated by qPCR in PG and SC from wild type mice of 
different ages (N=5-6 per group). (C and D) Further qPCR validation of mir-1949 expressions in whole PG, 
adipocytes and SVF from PG and in whole SC, adipocytes and SVF from SC, respectively (N=5-6). (E) Levels of 
mir-1949 in CM from ex vivo cultured PG isolated from mice of different ages was detected by qPCR (N=3-6 per 
group). (F and G) Senescence in 3T3 adipocytes induced with 0.2M glucose exposure for one week 
demonstrated with p16 elevation and SA-β staining (representivative of 3 independent manipulations). (H and I) 
elevated levels of mir-1949 in both senescent 3T3 adipocytes as wellCM from senescent 3T3 adipocytes (N=3). 
Data represent the mean  ±  SEM, *P<0.05, **P<0.01. 
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2. Possible actions of age-related mir-1949 on adipocytes 
To investigate the possible actions of this age-related miRNA on adipocytes, in vitro 
experiments with miRNA-mimic transfection was performed in 3T3-F442A adipocytes. RT-
qPCR result indicated that with transfection of 10nM mir-1949 mimic, its level was 
dramatically upregulated (Figure 7A). Classical functions of adipocytes, like glucose transport 
and lipolysis were not significantly affected by upregulation of mir-1949 (data not shown). 
However, in silico analysis with public database like Target Scan 7.0, suggested that some of 
genes involved in mitochondria functions were proposed to be potential targets of mir-1949. 
Therefore, we went back to in vitro expriments to investigate whether this miRNA would 
affect mitochondria in adipocytes. Interestingly, RT-qPCR results suggested that most of the 
mRNA levels were only slightly modified by the elevation of mir-1949, with Pgc1α was 
significantly decreased (Figure 7B). Then, the result of immunoblots of mitochondrial 
OXPHOS revealed that mir-1949 upregulation significantly decreased the level of complex II 
(Figure 7C), In agreement, functional analysis showed that the ability of oxygen consumption 
by complex II stimulated by its substrate succinate was significantly reduced by mir-1949 
upregulation (Figure 7D) in 3T3-F442A adipocytes. Therefore, mir-1949 might negatively 
regulate mitochondrial complex II level and function in adipocytes in vitro. Since 
mitochondria activation participates in the determination of lipid contents in adipocytes, we 
went on to investigate whether lipid contents was affected by mir-1949. Interestingly, 
BODIPY staining suggested that upregulation of mir-1949 promoted lipid accumulation in 
3T3-F442A adipocytes (Figure 7E). Moreover, upregulation of mir-1949 during adipogenesis 
by consecutively transfecting 3T3-F442A fibroblast every two days within 10 days , had a 
trend to increase classical white adipocyte gene markers such as Leptin and Glut 4 (n=2) 
(Figure 7F). 
In sum, with this preliminary in vitro results, we hypothized that mir-1949 might be 
able to modulate the lipid storage capacity of adipocytes via negatively affecting 
mitochondrial complex II acitivies and positively affecting adipogenesis process. 
Nevertheless, this hypothesis abosultely needs to be further validated by in vivo experiments. 
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Figure 7: In vitro actions of mir-1949 on adipcoytes.  
(A) 3T3 differentiated adipocytes were transfected with 10nM of the mimic sequence of mir-1949 or a negative 
control sequence. The levels of mir-1949 in adipocytes were detected 72 hours post transfection (N=3). (B) 
Levels of mRNAs were measured in 3T3 adipocytes by qPCR 72 hours post transfection (N=3). (C)  Protein levels 
of OXPHOS in 3T3 adipocytes were detected by immunoblots 72 hours post mir-1949 mimic transfection (N=3). 
(D) Succinate stimulated oxygen consumption by mitochondrial complex II was measured in 3T3 adipocytes 72 
hours post transfection (N=3). (B) 3T3 adipocytes were stained by BODIPY 72 hours post transfection of mir-
1949 mimic (representative of three independent manipulations). (F) 3T3 preadipocytes were consecutively 
transfected with 10nM mir-1949 mimic within differentiation. Then gene markers for adipocytes were detected 
by qPCR (N=2). Data represent the mean ± SEM, *P<0.05, ***P<0.001. 
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CONCLUSION AND PERSPECTIVE 
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The fact that caloric restriction promotes healthy aging in diverse species reveals that 
systemic metabolism is crucial in longevity373. In following, several conserved nutrient-
sensing pathways, such as, insulin-like growth factor-1 signaling, mTOR, AMPK and sirtuins 
have been identified as concerved moleculars in aging374. Aging witnesses dysfunctions in 
metabolisms. Specifically, during glucose tolerance test, old people could not handle the 
glucose stimulation as well as the young, needing to produce significant more insulin to get 
rid of the exogenous glucose375, indicating that that the peripheral metabolic tissues have a 
reduced efficiency to utilize the glucose. So, what kind of tissues responsible for this 
phenomenon? Currently, plenty of researches have indicated that aged liver and age muscle 
make contributions to the insufficient insulin sensitivity in aging376-379. For example, 
senescence drives lipid accoumulation and thereby steostasis in liver impairing its metabolic 
activities376.  
However, relative less attention has been put on another important tissue in 
metabolism, which is white adipose tissue, one of the largest human organs124. Adipose 
tissue is crucial in the regulation of systemic energy homeostasis. Despite the classic view 
that adipose tissue as an inert lipid tanker, elevating novel molecules in adipose tissue are 
revealed to process vital functions in recent years. In 2012, the work of Ronald Kahn’s group 
demonstrated that dicer was reduced in adipose tissue as well as in isolated adipocytes in 
aging in mice174, indicating that dicer/miRNAs might be novel molecules linking adipocytes 
and aging process. 
With the use of the inducible adipocyte dicer knockout transgenic mice, we 
demonstrated that adipocyte dicer deficieny promoted the onset of some age-related 
complications. For example, adipocyte dicer deficiency significantly reduced perigonadal 
adipocytes’ lipid storage capability, one of the age-associated dysfunctions in aging380. 
Moreover, the result that nutrient restriction, a process promoting healthy aging, positively 
regulates dicer level in adipocytes, further supports that there is a concered aging pathway 
in adipocytes involving dicer. Mechanistically, molecules like FOXOs, mitochondrial ROS and 
detoxification system might be involved in the actions of dicer in adipocytes in aging (Figure 
8B). 
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A. Adipocyte dicer abundance has a positive role in the prevention of age-assoicated 
complications.  
The dramatic reductions in classical white adipocytes markers, like Leptin and Glut 4, 
HSL, as well as the reduction in LD coating proteins like Fsp27 and PLIN1, suggesting that 
dicer is indispensible for the maintanence of white adipocyte identity as well as the 
homeostasis of LD inside white adipocytes.  
Surprisingly, PGC1α, one of the transcriptional factors important for the 
mitochondrial biogenesis and functions was increased due to dicer deficiency in perigonadal 
adipocytes. In addition, mitochondrial OXPHOS electron transport chain protein complexes 
were significantly increased or had a trend to be increased. These data indicated that there 
was an activation of mitochondria due to dicer loss in perigonadal adipocytes. 
Activation of mitochondria has recently been proposed to have metabolic benefits in 
subucutaneous adipose tissue381. However, the role of mitochondria in perigonadal 
adipocytes is relative less well understand. Since mitochondrial respiration is a major source 
of ROS in cells, therefore, to evaluate the state of mitochondria more comprehensively, it 
remains necessary to detect the ROS levels after dicer reduction in adipocytes. Surprisingly, 
there was a down regulation of antioxidants indicated by reduced mRNA levels of Catalase 
and Sod, indicating that there might be insufficiency in detoxification system. Moreover, the 
results that there was a trend for senescence markers like p16 and pP53 (Figure 8A) to be 
increased due to adipocyte dicer deficiency, further supported the possibility that the 
combination of mitochondrial activation and detoxification reduction leads to DNA damage 
in adipcoytes by dicer deficiency. 
According to literature, the transcriptional factor FOXOs has been reported to be able 
to promote the transcription of antioxidant genes like Sod and Catalase367, whereas 
inhibiting the transcription of genes involved in mitochondrial biogenesis and functions368.  
The transcriptional activity of FOXOs can be regulated by acetylation and phosphorylation382. 
For example, phosphorylatin of FOXOs will lead its nuclear exclusion into cytoplasma, 
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thereby inhibiting their transcriptional activies367. Interestingly, the result that adipocyte 
dicer deficiency increased the phosphorylation of both FOXO1 and FOXO3a, indicating that 
adipocyte dicer deficiency might negatively affect the FOXOs activities. FOXOs are key 
regulators of cellular response to various stresses and have been identified as a concerved 
molecule in promoting healthy aging383. One of the mechanisms that FOXOs contribute to 
longevity is through regulation of autophagy384. For example, FOXO1 and FOXO3 active 
autophagy in various cell types to help to maintan protein homeostasis385. Then, the result 
that dicer deficiency decreased authophagy gene maker Bnip3, further supported the idea 
that adipocyte dicer deficiency might lead to FOXOs inactivation. Since autophagy is also an 
important process removing organelles inside cells, it remains to be solved whether the 
inhibition of autophagy by dicer deficiency in adipocytes might have a role in mitochondrial 
degradation in vWAT. 
 
 
 
Figure 8: Proposed molecular mechanisms underlying adipocyte dicer in aging. 
(A) The protein level of pP53 in perigonadal adipose tissue in control and iADicer KO mice. (B) Simple scheme of 
possible mechanisms underlying adipocyte dicer in aging. 
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Therefore, to illustrate well the molecular mechanisms of adipocyte dicer in aging,  
On one hand, to further confirm the involvement of detoxidication system, several 
questions need to be addressed more clearly. 
1. Firstly, adipocyte dicer level negatively associates with cellular ROS levels? 
The answer to this question is probably crucial to determine whether adipcoyte 
dicer will induce oxidative stress and thereby DNA damage. Therefore, to resolve 
this question, in vivo, we propose to measure cellular ROS levels in adipocytes in 
control and iADicer KO mice. In vitro, we propose to measure cellular ROS levels 
in adipocytes in normal 3T3-F442A adipocytes or in 3T3-FF442A adipocytes 
overexpressising dominant-negative dicer. 
2.  Secondly, adipocyte dicer loss reduces the enzymatic activities of SOD and 
CATALASE? 
We’ve already demonstrated that the mRNA levels of antioxidant proteins: Sod 
and Catalase were dramatically reduced due to adipocyte dicer deficiency. 
Therefore, to be more convincing that adipocyte dicer deficiency induced 
detoxidication reduction, the enzymatic activities of these antioxidants need to 
be well addressed in adipocytes in control and iADicer KO mice. 
3. Thirdly, antioxidants will delay the age-related complications caused by adipocyte  
dicer deficiency? 
To well support the hypothesis that oxidative stress partly contribute to the 
accelerated onset of age-related complications by adipocyte dicer deficiency, it’s 
worthy of investigation whether the supplementation of antioxidants  (vitamin 
C, N-acetylcysteine, and Trolox)  to iADicer KO mice, would help to resuce the 
accelerated age-associated complications in iADicer KO mice. 
 
On the other hand, the involvement of FOXO1/FOXO3a in the role of adipocyte dicer 
in aging process needs to be further clarified. 
1. Firstly, our present data suggests that dicer deficiency induces increased 
phosphorylation FOXO1/FOXO3a, indicating their nuclear exclusion into 
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cytoplasma. Therefore, to better support this result, their cellular compartmental 
distributions need to be determined by immunohistochemistry or by protein 
extrations from nuclear and cytoplasma in adipocytes from control and iADicer 
KO mice. 
2. Secondly, the transcriptional activities of FOXO1 and FOXO3a also should be 
determined in adipocytes from control and iADicer KO mice. 
3. Finally, whether overexpression of FOXO1 or FOXO3a specifically in adipocytes 
(achieved by injection of control AAV sequence or AAV-adiponetin-dicer into 
iADicer mice) will prevent the onset of age-related complications in iADicer KO 
mice? 
 
 
B. Our results suggested that adipocyte dicer deficiency promotes liver aging. 
Aging is associated with the severity and poor prognosis of various liver diseases 
including nonalcoholic fatty liver disease (NASH) and firbosis. For example, aged populations 
(those aged over 65 years), was reported to have a higher NASH prevalence rate than their 
younger counter parts (56 vs. 72%, P=0.02), and also displayed a higher rate of liver 
fibrosis378. Interestingly, by using iADicer KO mice, our results propose that adipocyte dicer 
deficiency might accelerate liver aging, through promoting lipid accumulation and fibrosis in 
liver. 
There are 2 possible mechanisms might be involved.  
Firstly, there’s a crosstalk between adipocytes and liver in aging through adipocytes-
derived miRNAs. 
1. To test this possiblility, we can make use of ZsGreenlx/lx/ Adiponectin-CreERT2 mice, 
in which adipocyte-derived proteins will have GFP signal induced by tamxofien 
treatment (Figure 9). By co-immunostaining of GFP and exosomes markers like 
CD63 in liver, it can help to determine whether liver can uptake adipocyte-
derived exosomes under physiological states.  
2. In addition, through comparision of miRNA profile in exosomes extracted from 
circulations as well as miRNA profile in liver in control and iADicer KO mice by 
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microarray, it might help to determine if adipocyte dicer deficiency would lead to 
specific miRNA reduction in both circulating exosomes as well as in liver, which is 
needed for the maintenance of liver integrity and function in aging. 
 
Secondly, inefficiency of adipocytes’ capability of lipid storage leads to ectopic lipids 
in pheripheral liver. 
To test this possibility, the functions of adipose tissue like lipolysis, glucose transport 
and de novo lipogenesis need to be well studied in control and iADicer KO mice. 
 
 
Figure 9: GFP expression in adipocytes from ZsGreen
lx/lx
/adiponectin-CreER
T2+ 
mice by 4-hydrotamoxifen. 
Perigonadal adipocytes were isolated from ZsGreen
lx/lx
/adiponectin-CreER
T2+ 
mice and cultured in vitro. GFP 
expression was induced by 4-hydrotamoxifen treatment. 
 
 
C. Age-related mir-1949 might have a positive role in the prevention of age-related 
dysfunctions in adipocytes. 
In our above data, we’ve demonstrated that adipocyte dicer deficiency would 
promote the onset of some age-related complications, such as impaired lipid storage and 
systemic metabolic dysfunctions. However, in that part, we could not determine whether 
these are direct consequences of the dicer protein per se, or indirect consequence of some 
dicer produced miRNAs. Therefore, in my second part, we aimed at the selection of age-
related miRNAs in adipocytes. 
Interestingly, we firstly reported that aging increased mir-1949 expression in 
adipocytes in mice. Additionally and possiblity, aging might also promote the secretion of 
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mir-1949 from adipocytes. Moreover, in vitro data indicated that adipocytes senescence also 
increased mir-1949 production and secretion from adipocytes. 
Funtionally, however, we did not observe significant effects of this miroRNA in 
glucose transport and lipolysis in normal adipocytes in vitro. Interestingly, PGC1α was 
significantly reduced by mir-1949 upregulation in 3T3-F442A adipocytes, indicating that mir-
1949 might affect mitochondria in adipocytes. Susequently, the results that mir-1949 
upregulation led to a reduction in mitochondrial complex II protein level and oxygen 
consumption ability, further suggesting that mir-1949 might negative regulate mitochondria 
in adipocytes. 
Interestingly, Bodipy staining suggested that upregulation of mir-1949 promoted lipid 
accumulation in adipocytes, coinside with that mir-1949 negatively regulates mitochondria 
and thereby a reduced lipid utility. Interestingly, at the same time, continuous upregulation 
of this miroRNA during adipogenesis of 3T3-F442A preadipcoytes, exhibited a trend to 
increase the expression of classical white adipocyte gene markers, indicating that mir-1949 
might promote lipid storage in adipocytes. Moreover, this effect was only observed at the 
end of differentiation but not during differentiation (data not shown), suggesting that 
mature adipocytes are more sensitive to mir-1949’s effects. 
Then, interestingly, our preliminary results that upregulation of mir-1949 tended to 
increase lipid accumulation in senescent adipocytes as well as nutrient deprivation 
significantly increased its level in perigonadal adipose tissue in mice (Figure 10A and 10B), 
lead us to hyphothezse that this age-related microRNA might try to resuce age-related 
dysfunctions in adipocytes by modulating lipid storage capacity as well mitochondrial 
activities.  
Therefore, to further validate this hypothesis, in vivo experiments such as injection of 
AAV-aP2-mir-1949 into old mice (specific upregulation of mir-1949 in adipocytes), would be 
helpful to determine whether specific upregulation of this microRNA in aged adipocytes 
would help to rescue age-related complications in mice. In vitro, to better characterize the 
actions of mir-1949 on senesencet adipocytes, such as, gene profiles, functions, etc. 
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Figure 10: Possible role of mir-1949 in the prevention of age-related dysfunctions. 
(A) Adipocyte senescence was induced by exposure to 0.2M glucose for one week. Then, senescent adipocytes 
were transfected with 10nM of the mimic sequence of mir-1949 or a negative control sequence (N=1). (B) Mir-
1949 level in perigonadal adipose tissue in wildtype mice fasted for 24h (N=5). Data represent the mean ± SEM, 
*P<0.05. 
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MATERIALS AND METHODS 
Reagents and cell culture 
The 3T3-F442A cell line (ATCC) was maintained in Dulbecco’s modified Eagle’s medium 
(DMEM) medium supplemented with 10% of fetal bovine serum (FBS, Gibco®). 
Differentiation was induced by incubating confluent cells in differentiation medium (DMEM 
supplemented with 10% FBS plus 50nM insulin for up to 14 days. Cells were routinely 
cultured in 5% CO2 at 37°C. SiRNA for Dicer were purchased from Santa Cruz. 
AMPK activator AICAR and L-Ascorbic acid were obtained from sigma. 
Animal studies and Genotyping 
Mice used in this study were males of C57/BL6J background. 
Dicerlx/lx:adipoQ-CreERT2 mice were generated by crossing Dicer-floxed mice that possessloxP 
sites flanking exon 23 of the Dicer1 locus386, with adipoq-Cre/ERT2 mice, which express a 
tamoxifen-inducible CRE recombinase in adipocytes387. 
For genotyping, DNA was extracted from the tips of mice’ tails with the REDExtract-N-Amp 
Tissue PCR Kit (Sigma) and PCR was performed with the KAPA Mouse Genotyping Kit (KPAB 
BIOSYSTEMS). 
Tamoxifen (sigma) was dissolved in coin oil at 40°C overnight. Mouse wasorally 
administrated with tamoxifen (200mg/kg) for 5 consecutive days for 3 times with around 2 
months. 
Immunofluorescence 
PLIN1 were performed with commercial kits (PROGEN and ThermoFisher Scientific, 
respectively) with slight modifications. Briefly, cells were rinsed with PBS, fixed with 
methanol for 5 mins on ice, and then rinsed with PBS twice. Primary antibody for PLIN1 was 
diluted in 1 to 200 inside 1 % BSA inside PBS, and laid on the surface of slides for incubation 
at 4°C overnight. Fluorescent second goat anti-Rabbit antibody (InvivoGen), which was 
diluted in1 to 100 in 1 % BSA was incubated with cells for 30mins at RT in dark. Slides were 
rinsed with PBS and then mounted with fluorescent mounting medium (Dako). Pictures were 
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taken with microscopy. Lipid droplets were stained with BODIPYTM 493/503 (ThermoFisher) 
as described 388. 
Histological Analysis 
Adipose tissues and liver were immediately excised and fixed in 4% paraformaldehyde and 
embedded in paraffin. Sections of 5μm were stained with hematoxylin and eosin (H&E), and 
imaged with Nikon microscope. Adipocyte sizes were quantified with Adiposoft software as 
described389. 
Sirud red staining 
The liver sections of 5μm were stained with 1% Sirus Red F3B (Sigma) in saturated picric acid 
(Sigma). The quantification of the red-stained collagen area was performed with Image J 
software. 
Quantification of plasma parameters 
Blood samples were taken from the portal vein of mouse, with EDTA, plasma were separated 
by centrifugation at 10000 rpm for 10 min at 4°C and were stored at -80°C. Plasma 
parameters were detected by Centre Régional d’Exploration Fonctionnelle et de Resources 
Expérimentales, INSERM, Université Paul Sabatier (CREFRE). 
Western Blot and antibodies 
Cells were lysed in Laemmli buffer. Mouse tissues were homogenized in RIPA buffer 
supplemented with protease inhibitor, phosphatase inhibitor cocktail 1 and cocktail 2 
(Sigma), and protein extracts were quantified using Bradford method (Bio-Rod). Proteins 
were electrophoresed on 15 % SDS-polyacrylamide gels and transferred to nitrocellulose 
membrane (Bio-Rad). Membranes were blocked and incubated with primary antibodies in 5 % 
BSA in PBST overnight at 4°C. Blots were the rinsed and incubated with secondary antibodies 
conjugated to horseradish peroxidase (HRP) (Sigma). Immunoreactivity was detected by 
Amersham ECL prime Western Blotting Detection Reagent (GE Healthcare) and visualized 
with the ChemiDoc XRS+ system (Bio-Rad). Information about sources of antibodies was 
listed as following: 
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GAPDH( Ref: mAb2118, Cell Signaling TECHNOLOGY (CST)); HSL (Ref: 4107, CST); Dicer (Ref: 
sc-136979, Santa Cruz); Phospho-Akt(ser473) (Ref: 9271); AKT (Ref: 9272, CST); Phospho-
AMPKα (Thr172) (Ref: 4188, CST); AMPK (Ref: 2532, CST); PPARγ (Ref: 2430, CST); FAS (Ref: 
sc-20140, Santa Cruz); Total OXPHOS Rodent WB Antibody Cocktail (Ref: ab110413, 
Mitosciences); PGC1α (Ref: ab54481, Abcam); LC3B (Ref: 2775, CST); Phospho-FoxO1 
(Thr24)/FoxO3a (Thr32) (Ref: 9464, CST). 
Lipolysis assay 
3T3-L1 adipocytes were previously starved with DMEM for 4h and then treated with 
DMEM supplemented with 2.5% fatty acid free bovine serum albumin (sigma), containing 0 
or 10-6 isoproterenol for 2 hours. Glycerol released in the medium was measured with the 
Glycerol-Free Reagent Kit (Sigma). Results were normalized to the levels of total proteins 
measured by Bradford methods (Bio-Rad). 
Glucose transport 
Cells were starved in serum-free DMEM for 6 h and then incubated in the absence or 
presence of 100nM insulin in Krebs-Ringer phosphate buffer (pH 7.4) supplemented with 0.2% 
bovine serum albumin, for 45minutes at 37°C. Transport was started by adding 4μCi /1 ml 
[3H]2-deoxy-D-glucose (NEN, Boston, MA) for 10 minutes precisely and stopped by placing 
the cells on ice and rapidly washing them with ice cold 10mM glucose in PBS. Cells were 
lysed with 0.05N NaOH. Aliquots of the cell lysates were used for liquid scintillation counting 
and determination of protein contents by the Bradford method (Bio-Rod), respectively. 
Senecence-associated β-Galactosidase staining (SA-β-gal) 
Β-gal activity was detected at pH 6, a known characteristic of senescent cells not found in 
quiescent or immortal cells with commercial kit from Cell signaling TECHNOLOGY (Ref: 9860). 
Triglyceride content measurement 
Cells were rinsed with PBS and lysed in PBS by brief sonication. TG was measured by 
determination of the concentration of glycerol released after lysing and enzymatically 
hydrolyzing the triglyceride molecules. Free glycerol reagent and Triglyceride reagent kit 
were obtained from sigma. 
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Measurement of mitochondria oxygen consumption 
Oxygen consumption was determined at 37°C using the Oxygraph-2k (O2k, OROBOROS 
instruments). Cells were permeabilized with 0.1% saponin (Sigma) in BIOPS (2.77mM 
CaK2EGTA, 7.23mM K2EGTA, 5.77mM Na2ATP, 6.56mM  MgCl2∙6H2O, 20mM Taurine, 15mM 
Na2Phosphocreatine, 20mM Imidazole, 0.5mM Dithiothreitol, 50mM MES hydrate) with 
gentle vegetation at 4°C for 20 mins. Permeabilized cells were respirated in MiR05-Kit 
(110nM D-Sucrose, 60mM K-Lactobionic acid, 0.5mM EGTA, 3mM MgCl2, 20mM Taurine, 
10mM KH2PO4, 20mM HEPES). The following substrates L-Glutamic acid at 2000mM, L-Malic 
acid at 400mM and Succinate at 1000mM were applied. 
RNA Extraction and Quantitative RT-PCR (qPCR ) 
For the analysis of mRNAs, cells or tissues were lysed with QiAzol lysis reagent (QIAGEN), 
and RNA was extracted with RNeasy Mini Kit (QIAGEN). The cDNA templates were prepared 
by reverse transcription of RNA (500ng) using High-Capacity cDNA Reverse Transcription kit 
(ThermoFisher) and gene expressions were measured using a MESA blue qPCRTMMastermix 
plus for SYBR assay (Eurogentec). 
For the analysis of miRNAs, total RNA was extracted with MasterPureTMComplete DNA δ RNA 
Purification kit 2.00 (EUROMEDEX) according to manufacturer’s instructions. 10ng of total 
RNA were reverse transcribed using TaqMan TM MicroRNA Reverse Transcription Kit (Applied 
Biosystem) and qPCR and data evaluation were performed as described previously228. The 
amplification data were analyzed using Viia7 (Applied Biosystems). 
Statistical Analysis 
All calculations were performed by using Prism 5 (GraphPad Software, USA). Statistical 
significance between two groups was determined by the Student’s t test. Statistical 
significance was set at p < 0.05. 
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Project II: 
A novel method of culturing isolated adipocytes in vitro 
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The striking rise of obesity-related metabolic disorders has focused attention on 
adipocytes as critical mediators of disease phenotypes. To better understand the role played 
by excess adipose in metabolic dysfunction, it is crucial to decipher the characteristics of 
adipocyte per se. However, during my PhD project, we found that it was very hard to 
successfully modulate gene expressions in vitro in differentiated adipocytes from 
immortalized cell lines, such as 3T3-F442A cells, with routine techniques like siRNA 
transfections. Therefore, a practical method for studying adipocytes in vitro is absolutely 
necessary for development of therapeutic targeting adipocyte. 
Taking into considerations of the present situations of in vitro adipocytes models that 
are introduced in the introduction part, we are wondering why there is no established 
protocol for directly culturing isolated adipocytes. Two major questions might need to be 
uncovered as following: 
- What is the main technical difficulty preventing the possibility of culturing 
adipocytes in vitro directly? 
- Through what kind of interventions tha we could overcome these roadblocks? 
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Result 2: A novel method of culturing isolated adipocytes in vitro 
1. Working scheme for culturing isolated adipocytes in vitro 
The unique characteristics of adipocyte come from their structure: one big lipid 
droplet (LD) taking place of nearly all the cytoplasm (around 90%), which will result in 
extreme buoyancy forces to fat cells in aqueous system. Naturally, adipocyte would float on 
top of the culture medium which has a higher density than lipids. Consequently adipocytes 
will shortly die beacause of surface tension between atmosphere and the liquid culture 
medium, as well as poor nutrition. Therefore, it is necessary to solve this question in order to 
successfully culture mature adipocytes in vitro. Possibly, the solution is either to prevent the 
floating of buoyant adipocyte mechanistically or to modify the density of culture medium 
making it lower than that of fat. Herein, we tried to sequester adipocyte with the application 
of cell culture inserts by immersing them underneath the membrane of inserts (Figure 1A). 
However, since previous “ceiling culture”, where adipocyte were allowed floating on top of a 
glass flask or a cover slide on top of wells of culture plates which were fully filled with 
medium, resulted in dedifferentiation, deform or death of cells359,390, we suggest that there 
are other factors affecting the lipid storage capability of adipocyte (LDs stability) or viability 
of adipocyte in vitro. 
To reslove this question, it is crucial to understand the unique properties of LDs 
inside adipocyte. Structurally, LDs are composed of a neutral lipid core, consisting primarily 
of triglyceride and sterol esters, which are covered by a monolayer of phospholipids as well 
as other amphiphilic lipids, and proteins391,392. For example, perilipin is the most abundant 
amphipathic protein on the surfaces of adipocyte LDs 393, which is the major substrate for 
cAMP-dependent protein kinase (PKA) in lipolytically stimulated adipocytes. Perilipin serves 
important functions in the regulation of basal and hormonally stimulated lipolysis. Unlike the 
two leaflets of a bilayer, which are physically coupled, this monolayer can be stretched 
infinitely, resulting in an increasing surface tension. LDs with high surface tension are 
unstable and tend to fuse394. 
Between the LDs and the bilayer phopholipid cell membrane is the scarce cytosol, a 
complex mixture of cellular organelles and substances dissolved in water. Due to the 
extreme limited proportion of cytosol in adipocyte, its buffer effects of preventing the LDs 
118 
 
from alterations in extracellular compartments, are dramatically weakened. For instance, it 
would be possible that immediate immerse adipocytes into pure H2O would lead to rapid 
osmosis of water into cytosol through cellular membrane, and then because of the extreme 
limited room of cytoplasm inside adipocyte, this swelling of cytosol might lead to the final 
destruction of cellular membrane  and thereby cell death. On the other hand, it would be 
also possible that immerse adipocytes into a solution which is higher concentrated than the 
cytosol of adipocytes would result in dehydration of adipocyte cytosol and thereby reduced 
cell viability (Figure 1B). Therefore, it is crucial to control the osmotic pressure of 
extracellular medium in order to maintain the homeostasis of adipocyte cytosol. 
Glycerol is a well-known hyperosmolar agent and has a low toxicity. In addition, 
glycerol protects red cells against the trauma of freezing and thawing395. Therefore, in an 
attempt to modify the osmosis of culture medium, we tested thether the supplement of 
glycerol into culture medium would help to inmporve the survival rates of adipocytes (Figure 
1C). 
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Fig 1: Illustration of the working scheme. 
(A) Application of cell inserts to sequester buoyant adipocytes from floating for culturing in vitro. (B) Possible 
influence of the homeostasis of adipocyte cytosol by environmental tonicity. (C) The chemical structure of 
glycerol. 
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2. Modifications of culture medium 
To investigate the morphology of cultured adipocyte, microscopy observation was 
applied and it was shown that fat cells exhibited a ball like spherical 3D structure (Figure 2A 
and 2B), with a relatively smaller nucleus which is peripherally located (Figure 2A and 2C), 
and the LDs nearly taking up of all the cytoplasma of adipocytes (Figure 2D). In addition, 
PHK26 which is a dye that identify the membrane structures, indicated that the cultured 
adipocytes maintained the integrity of cell membranes (Figure 2A). These data indicate that 
isolated adipocyte cultured with our working scheme maintained the spherical integrity at 
least for a short period (within 3 days). However, at the same time, it was also found that the 
survival rates of these adipocyte were very low with dead cells exhibiting an appearance of 
shrinking cell membranes (data not shown), confirming that other factors aside buoyancy 
are affecting the vitality of the in vitro cultured adipocytes. Therefore, we went on to 
investigate whether modification of the osmolarity of culture medium by supplement of 
glycerol would help to improve the survival rates of adipocytes. 
Interestingly, glycerol supplement dose-dependently increased the survival rates of 
fat cells demonstrated with TUNEL staining (Figure 2E). The reason why there was the 
appearance of shrinking of cell membranes cultured with low concentration of glycerol is not 
well understand. Here we proposed that one of the factors leading to the crushes of the 
spherical 3D adipocytes might come from the osmosis of hypotonic culture medium into cell 
cytosol, resulting in imbalance of the homeostasis of cell cytoplasm and plasma membrane 
integrity and finally cytotoxicity. 
On the one hand, to set up a better culture condition, we went on to select a suitable 
fetal bovine serum (FBS) concentration. Interestingly, we observed that when cultured 
without serum, fat cells started to exhibit strange alterations, which was “browning of the 
color” while still retaining the morphological integrity (Figure 2F). TUNEL assay helped to 
demonstrate that fat cells started apoptosis without serum, indicating that serum 
deprivation could also lead to apoptosis of terminal differentiated adipocytes. On the other 
hand, fat cells cultured with 20% FBS, exhibited “crushed” structures, which was 
demonstrated with TUNEL assay as dead cells. The reason that very high concentrations of 
FBS led to death of fat cells might due to the increased osmotic pressure that lead to 
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dehydration (drain) of the very limited aqueous cytosol of adipocyte and then death. 
Adipocyte cultured with 10 to 15% FBS remain relatively normal in term of structure. 
Therefore, the concentration of FBS is also vital for the viability of adipocytes in culture, with 
both low and high concentrations would lead to apoptosis. 
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Fig 2: Image of adipocytes in culture under different condtions. 
(A) PHK26 and DAPI staining demonstrated that cultured adipocytes maintained the integrity of structures with 
normal cell membrane and peripherally located nucleus at D10 of in vitro culture. (B, C and D) Microscopic 
observations show that cultured adipocytes exhibted ball-like 3D spherical structures, with DAPI identified an 
extreme small and peripherally located nucleus and bodipy staining demonstrated that a single LD took up 
nearly of all of the cytoplasm at D2 of in vitro culture. (E) Adipocytes were cultured with different 
concentrations of glycerol (2.5%, 5% and 10%) and were observed and imaged daily. Tunel assay were 
performed 2 weeks after to detect apoptosis. (F) Adipocytes were cultured with different concentrations of FBS 
(0, 10%, 15% and 20%) and were observed and imaged daily. Tunel assay were performed one week after to 
detect apoptosis. Representiative of 3 independent manipulations. 
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3. Functional investigation of cultured adipocyte in vitro 
To investigate whether cultured adipocyte are biologically functional, we analysed 
various functional analysis. 
It is well known that insulin signal transduction triggers the phosphorylation of AKT at 
serine 473 through insulin substrate 1 (IRS-1) and phosphatidylinositol (PI) 3-kinase (PI3K), 
which is crucial for insulin stimulated glucose uptake into adipocyte. The result 
demonstrated that 100nM insulin stimulation increased the level of pAKT (s473) in cultured 
adipocytes (Figure 3A), indicating that sensitivity of insulin pathway is conserved.However, it 
was also noted that the basal level of AKT phosphorylation of AKT at serine 473 was high 
even after deprivation, which might due to the structure of culturing system, because it is 
impossible to change all the medium at one time (some medium have to be remained to 
cover the sequestered adipocytes), instead, dual dilutions of previous culture medium with 
serum and glucose with DMEM.  
To investigate the glucose uptake ability of cultured adipocyte, we took advantage of  
a fluorescent D-glucose analog 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino ]-2-deoxy-D-
glucose (2-NBDG), which could directly measure glucose uptake in living cells 379. The result 
shows that 100 or 1000nM insulin stimulation had a clear trend to increase the uptake of 
fluorescent 2-NBDG into cultured adipocyte (Figure 3B). Unfortunately, because of the 
hyper-sizes of adipocytes, flow cytometry could not be applied to detect the difference of 
fuorescence. However, the result obtained with [3H] 2-deoxy-D-glucosetracer further 
demonstrated that insulin would significantly stimulate the glucose uptake into culture 
adipocyte by around 50% at the day 5 of culture (Figure 3C). Therefore, in vitro cultured 
adipocytes are capable of extacellular glucose intake. 
On the other hand, lipolysis was performed to evaluate the responsiveness of β3-
adrenergic signaling pathway of cultured adipocytes (Figure 3D). The result demonstrated 
that isoproterenol at the concentrations of 0.1 or 1μM successfully increased the glycerol 
release into medium by around 40 to 50% compared to basal release even at the day 8 of 
culture (0.39 ± 0.025 vs. 0.55 ± 0.037 and 0.60 ± 0.056 mM). In fact, it would apparently be 
observed that the size of adipocytes even reduced with isoproterenol stimulation (data not 
shown), indicating the dynamic of adipocytes. Technically, since adipocytes were cultured 
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with 10% of glycerol in medium, it required thorough refresh of the medium with glycerol 
free DMEM before the performance of lipolysis, which might lead to trauma to the delight 
adipocytes. Therefore, whether technical defects would result in effects of the results 
remain unknown. Nevertheless, these above results indicated that cultured fat cells were 
functional. 
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 Fig 3: Functional investigation of adipocyte in vitro. 
(A) Adipocytes at D5 of culture were previous starved in DMEM overnight followed by stimulation of 100nM 
insulin. Phosphorylation of Akt and total Akt were detected with immunoblot. (B) Adipocytes at D2 of culture 
were recovered into 1.5 ml tube, rinsed with DMEM, and then were stimulated with different concentration of 
insulin for 45 min, followed by incubation with 200mM 2-NBDG for 60 min. (C) Adipocytes at D5 of culture 
were previously starved in DMEM overnight followed by stimulation of 100 and 1000nM insulin. [
3
H] 2-deoxy-
D-glucose was used to evaluate glucose uptake. (D) Adipocytes at D8 of culture were previously starved in 
DMEM for 4h followed by stimulation of 0.1 and 1μM isoproterenol. Glycerol release in the medium was 
determined. Data represent the mean ± SEM, *P<0.05, **P<0.01. 
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4. Characterization of adipocytes during chronic culture in vitro 
The results of PLIN1 and BODIPY double staining demonstrated that there was a 
preserved expression of PLIN1 on the surfaces of LDs inside adipocytes as long as at D13 of in 
vitro culture (Figure 4A), suggesting that the LDs might be stable during the chronic in vitro 
culture. Therefore, we then decided to further characterize the influence of chronic in vitro 
culture on adipocytes by studying their cell sizes and gene expressions. 
Interestingly, characterization of the alteratioins in adipocyte size at D1, D3, D6 and 
D9, revelt that the average size of adipocytes had a trend to increase and peak at D6, after 
which it dropped again (Figure 4B) (N=1). Since the size of adipocytes reflect mainly the size 
of LDs inside adipocytes, which is mostly determined by the balance between lipolysis and 
lipogenesis. Thus, the possible alterations in adipocyte size might suggest that the cultured 
fat cells remain dynamic in terms of lipolysis and lipogenesis. To help find more clues about 
the effects of in vitro culture on adipocytes, RT-qPCR was performed to study the genetic 
profile of cultured adipocytes at D1, D3, D6 and D9. The adipocyte lipid binding protein aP2 
(fatty acid binding protein (FABP) 4) gradually increased and peaked at D6, after which it 
dropped back. It was also the same trend other genes like Adiponectin, Cebpα, Pparγ2, Pgc1β, 
CD36 and Fatp (fatty acid transport protein) (Figure 4C). These results might coincide with 
the morphological alterations of these fat cells (Figure 4B). However, genes like Leptin and 
Glut4 surprisingly and strangly kept decreasing at the onset of culturing (Figure 4C). The 
reasons why these were abnormal alterations of genes are not fully understood.  
Nevertheless, we then went on to see whether this system is applicable to human 
adipocytes. Preliminary results show that cultured human adipocytes had a much yellow 
appearance and could maintain their spherical morphology as long as at D11 (Figure 4D). 
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 Fig 4: Characterizations of adipocytes during chronic culture in vitro. 
(A) Triple stainings of adipocytes with BODIPY, PLIN1 and DAPI at the D13 of in vitro culture. (B) Alterations of 
cell sizes during culture. (C) Alterations of gene expressions in adipocyte during culture. (D) Applications of the 
method to culture human adipocytes. 
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CONCLUSION AND PERSPECTIVE 
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With the help of mechanical sequestering by cell culture inserts and supplement of 
glycerol into culture medium, we firstly reported that isolated adipocytes were able to 
remain spherical 3D structure for as long as nearly 2 weeks.  
PHK26 dye staining demonstrated the integrity of plasma membrane of cultured 
adipocytes, with DAPI detecting a very small and peripherally located nucleus after chronic 
culture. Dual staining of BODIPY and PLIN1, demonstrated that the preserved expression of 
lipid coating protein on the surface of LDs inside cultured adipocytes as long as 2 weeks of in 
vitro culture, indicating of preserved stability of LDs inside adipocytes with our novel culture 
system. 
The protection of glycerol supplement to adipocytes might due to the increased 
tonicity of hypertonic culture medium, which then modified the osmosis of water into the 
limited cytosol of adipocytes and thereby maintained the homeostasis of adipocytes 
cytoplasm and then the survival rates of the adipocytes. Next, the pro-apopotic effects of 
high concentrations of FBS (20 to 25%) on the other hand suggested that hypertonicty of 
medium by FBS might lead to dehydration of adipocyte cytosol and thereby cell death. All 
these data indicated that the balance of the tonictiy of culture medium is vital from culture 
mature adipocytes in vitro. 
Moreover, functional analysis revealed that cultured fat cells were responsive to 
insulin stimulated Akt phosphorylation and glucose uptake, as well as responsive to 
catecholamine stimulation demonstrated by increased lipolysis. Genomic analysis revealed 
that there were abnormalities in terms of gene expressions with present culture conditions. 
They might be related to the effects of collagen digestion and need to be further 
investigated. The reasons why these are abnormal alterations of genes were not fully 
understood. However, several factors might contribute to the above phenomenon: 
1) Trauma from collagenase digestion.  
The process of isolation of adipocytes from adipose tissue with collagenase A 
digestion was firstly set up by Rodbell M. in 1964345. Since then, this method was 
widely applied for the study of adipocyte biology with minor modifications. 
However, precise actions of the digestion process per se on adipocytes are largely 
unclear. We tried to evaluate the effects of digestion on the viability of 
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adipocytes by staining isolated adipocytes with trypan blue shortly after digestion 
process. The result showed that most of the isolated adipocytes were positively 
stained at only one point of cell surface by trypan blue (data not shown), a dye 
that is endocytosed only by cells with impaired plasma membranes, indicating 
that digestion process per se might lead to reduced viability of adipocytes and 
thereby affecting their genome integrity during the in vitro culture thereafter.  
2) Toxicity from fatty acids from broken adipocytes.  
One of the limits of the present culture system with cell insert is that it could not 
prevent certain adipocytes from escaping through the peripheral rim covered 
without cell insert, which later would float on top of medium and break due to 
surface tension between air and medium, releasing large amount of lipids onto 
the medium. Therefore, lipid toxicity on adipocytes from broken adipocytes could 
not be excluded. To resolve this possibility, supplementation of BSA (free fatty 
acid-free) into medium might be helpful to neutralize spilled lipids from dead 
adipocytes. 
3) Some nutrients or hormones are lacking in the medium to help preserve the 
genomic integrity of fat cells. 
In vivo, the physiology of adipocytes is elegantly maintained by various 
hormones like insulin, leptin, catecholamine, etc. Therefore, it is plausible that 
proper supplementation of a cocktail of hormones might be necessary to 
maintain the normal gene expressions of cultured adipocytes. 
 
In sum, for the first time, we demonstrated the possibility to culture isolated 
adipocytes in vitro with preserved morphology and LDs coating protein expressions as long 
as 2 weeks by glycerol supplementation. Functional studies confirmed that the cultured 
adipocytes were responsive to insulin and catecholamine stimulation. However, intriguing 
gentic profiles at different stage of in vitro culture, indicated that this technique is still at a 
preliminary stage with uncertainties, thereby might not be recommended for formal 
experiments. 
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Nevertheless, we image that in the further with progress in our technique protocol, 
we could directly modulate gene expressions in culture adipocytes by runtine gene therapy 
techniques like siRNA or CRISPR, which will better mimic in vivo situations. 
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MATERIALS AND METHODS 
Isolation and culture mature adipocytes 
Cell culture insert transparent PET membrane 12well 1.0μm pore size (Falcon, corining) were 
previous covered with 50µg/ml type I collagen (Santa Cruz, sc-136157) dissolved in 0.02N 
acetic acid for 1h at room temperature. Inserts were rinsed well with PBS and air dried under 
laminar flow hood before usage. Perigonadal adipose tissue was dissected from C57BL/6J 
background mice in accordance with the guidelines of the local ethical committee. 
Adipocytes were isolated after digestion in 1 mg/mL collagenase A (Roche, USA) for around 
40minutes at 37°C in a heat bath with brief shaking at intervals.  The digested tissue was 
filtered through a 100μm nylon mesh.  The filteredadipocyte were washed four to five times 
with DMEM/F12 containing 20% fetal bovine serum (FBS, Gibco).  The floating layer of 
adipocytes was isolated for culture.  300μl DMEM/F12 supplemented with 20 percent fetal 
bovine serum were seeded into each well of 12 well plates to cover the surface.Then, 30 μL 
of packed and floated fat cells were carefully seeded. After, 300ul of culture medium were 
carefully added into the upper side of the insert.  Medium was changed every two days using 
1ml syringe equipped with 23G needle.Cells were routinely cultured in 5%CO2, 37°C. Cells 
were observed with light microscopy. 
PLIN1/ BODIPY staining 
PLIN1/ BODIPY staining were performed with commercial kits (PROGEN and ThermoFisher 
Scientific, respectively) with slight modifications. Briefly, cells were rinsed with PBS, fixed 
with 100 percent methanol for 5 mins on ice, and then removed the methanol and rinsed 
cells with PBS twice, and keep the cells on ice for 15 mins. Primary antibody of perilipin was 
diluted in 1 to 200 inside 1 percent of BSA inside PBS. Carefully lay the primary antibody on 
the membrane of MILLICELL insert and incubated at 4 degree for overnight. Removed the 
primary antibody from the upper or down of the membrane, rinsed 3 times with PBS. 
Fluorescent second goat anti-Rabbit antibody (InvivoGen), which was diluted at the ratio of 1 
to 100 in 1 percent BSA in PBS was incubated with cells at RT for 30mins in dark. After, cells 
were rinsed with PBS for 3 times, and further incubated with Bodipy (10l/ml) and Hoechst (1 
to 50000) solution for another 30 min. Pictures were taken with microscophy. 
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TUNEL assay 
Apoptotic or necrotic cells were detected by the terminal deoxynucleotidyltransferase (TdT)-
mediated dUTP nick end labeling (TUNEL) method using TUNEL Assays kit from RδD Systems. 
Western blot 
Cells were lysed with Laemmli buffer containing 0.2 % SDS. Proteins were electrophoresed 
on 15 % SDS-polyacrylamine gel and transferred to nitrocellulose membrane (Bio-Rad). 
Membranes were blocked and incubated with primary antibodies in 5 % BSA in PBST 
overnight at 4°C. Blots were the rinsed and incubated with secondary antibodies conjugated 
to horseradish peroxidase (HRP) (Sigma). Immunoreactivity was detected by Amersham ECL 
prime Western Blotting Detection Reagent (GE Healthcare) and visualized with the 
ChemiDoc XRS+ system (Bio-Rad). Information about sources of antibodies was listed as 
following: GAPDH (Ref: mAb #2118, Cell Signaling TECHNOLOGY (CST)); Phospho-Akt (ser473) 
(Ref: 9271); AKT (Ref: 9272, CST). 
Quantitative real-time PCR 
Total RNA was isolated from cultured adipocytes, using MasterPureTMRNA purification kit 
(Epicentre, USA) according to manufacturer’s instructions. The cDNA templates were 
prepared by reverse transcription of RNA (500ng) using High-Capacity cDNA Reverse 
Transcription kit (ThermoFisher scientific, USA)and gene expressions were measured using a 
MESA blue qPCRTMMastermix plus for SYBR assay (Eurogentec, Belgium). The amplification 
data were analyzed using Viia7 (Applied Biosystems). 
Lipolysis assay 
10μl of packed adipocytes were seeded into each well of corning  HTS transwell 96 well 
permeable supports, pore size of which was 3.0 μm (sigma, cat. No.:CLS3385). At the 8th day 
of culture, 100 μl lipolysis buffer (KRBS buffer plus 0.1% glucose and 3.5% fatty acid-free 
bovine serum albumin, sigma) containing 0 or 10-6 isoproterenol was added into the 96-well 
plate for 4h at 37°C. The glycerol assay (Sigma) was used to measure glycerol concentrations 
in the medium, as manufacturer’s instructions. 
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Glucose transport 
Cells were starved in serum-free DMEM without glucose for 6 h. Cells were then transferred 
into 1.5 mL eppendorf for incubationwith or without insulinin Krebs-Ringer phosphate buffer 
(pH 7.4) supplemented with 3% fatty acid-free bovine serum albumin (Sigma) for 45minutes 
at 37°C.Transport was started by adding 4μCi /1 ml [3H]2-deoxy-D-glucose (NEN, Boston, MA) 
for10 minutes precisely at 37°C and stopped by addition of  cytochalasin B (Sigma). After 
aliquots of adipocytes were then transferred into microcentrifuge tubes with 200μl and then 
separated from incubation buffer by brief centrifugation and were used for liquid 
scintillation counting. Resting aliquots of adipocytes in incubation buffer were used for DNA 
detection with Quanti-iT TM PicoGreen TMdsDNA Assay Kit (ThermoFisher). Final results of 
DMP were then normalized to DNA levels. 
2-NBDG uptake 
Cultured adipocytes were recoverd into 1.5mL eppendof, rinsed briefly with PBS, and then 
incubated in DMEM containing 0 or 100nM insulin for 60 min at 37°C. Then, 250mM 2-NBDG 
was incubated with cells for another 30 min at 37°C. Fluorensencent uptake of 2-NBDG were 
imaged with microscope. 
Statistical analysis 
Statistical analysis was performed using GraphPad Prism7.0 software (GraphPad Software, 
USA). Adipocyte sizes were analyzed with image J software. P<0.05 was considered 
statistically significant. 
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